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2.1 The replication of DNA 
DNA replication is the process of copying the entire genome of a cell during 
proliferation. This extraordinary task is carried out with remarkable efficiency in living 
organisms: a fertilized egg goes though 5 trillion cell divisions to develop into an adult 
human, creating 20 billion kilometers of DNA in the process (DePamphilis 2006). 
The workhorse behind this process is the DNA polymerase. Bacterial polymerases copy 
up to 100.000 bases of DNA each minute, allowing them to replicate their entire genome 
in minutes with error rates as low as 1 in 100 million basepairs (Kornberg & Baker 2005; 
Kunkel 2004). In eukaryotes, genome sizes are drastically increased, and the 
sophisticated eukaryotic replication machinery only handles about 2000 bases per minute. 
Therefore, with a single polymerase it would take 20 years for a human cell to divide, 
whereas in reality this task is accomplished in about 8 hours. To achieve this, eukaryotic 
cells have developed a way to parallelize replication by starting it in multiple locations. 
These start sites are named replication origins, which are functional genomic locations 
that allow the recruitment of the replication machinery. 
This thesis deals with the protein Orc6, a subunit of the human origin recognition 
complex (ORC). This complex is the first to recognize and bind to replication origins 
during the cell cycle. To place Orc6 into the context of the human cell and DNA 
replication, first replication initiation and origins are discussed in more detail. 
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2.1.1 The replicon Model 
The existence of origins was first suggested in the 1960s by François Jacob (Jacob et al. 
1963). The replicon model, based on studies in bacteria, proposed a cis-acting replicator 
element, and a trans initiator element, the recruitment of the latter triggering replication 
initiation (Figure 1). The replicon itself was defined as a stretch of DNA, which is 
replicated from a single origin. 
 
 
Figure 1. The replicon model. This drawing in the sand represents the model proposed by François Jacob, 
Sydney Brenner and Francois Cuzin to explain how DNA replication initiates. It depicts the circular 
bacterial genome with a box as the replicator element (Jacob et al. 1963). In order for replication to start, 
the trans acting initiator element (indicated by the arrow) is recruited. Image: (Thomae 2008; Skarstad et al. 
2003) 
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Such a single replicon system is typical for bacteria, and at the time it was postulated that 
the larger genomes of eukaryotes simply have several replicons next to each other, which 
are activated in a pre-determined order (Gilbert 2004). More recent studies however 
found eukaryotic replication initiation to be more complex. 
2.1.1.1 The replicator 
The replicator element is the cis-acting structure, which defines the locus where DNA 
replication commences. Different organisms have developed different replicators, which 
are referred to as origins of replication. 
Bacteria have origins similar to the structure proposed in Figure 1, where a single, 
genetically defined origin sequence serves as the replicator. In Escherichia coli this is the 
250bp oriC element, which is sufficient to replicate the circular, 4.6mb long prokaryotic 
genome (Mott & Berger 2007). OriC consists of three, AT rich 13-mers and four 9-mer 
repeats, which are all crucial for replication (Leonard & Grimwade 2010). Bacterial 
plasmids, being independent, circular pieces of DNA in prokaryotes, also contain a 
replicator sequence. These have been well characterized for use in genetic engineering, 
such as the pUC origin sequence, which I also took advantage of for creating bacterial 
plasmids, as this allows stable, high copy number presence of plasmids in E. coli 
(Herman et al. 1994). 
Archaea, despite being prokaryotes, have replication machineries related to eukaryotes. 
They use multiple origins to replicate their circular genome. These replicators are poorly 
characterized to date, have no known consensus motifs, but are generally AT rich, 
contain inverted repeats and are often in close proximity of initiator genes (Kelman & 
Kelman 2003; Kelman & Kelman 2004). 
The first origins in eukaryotes were found in the budding yeast Saccharomyces 
cerevisiae. These were initially described as sequences which initiate replication if 
introduced into plasmids, and were therefore named autonomous replicating sequences 
(Stinchcomb et al. 1979). ARS elements have two conserved regions: A and B, the latter 
often divided into B1 and B2, while some ARS elements also contain a B3 sequence. 
ARS1, the first yeast origin studied in detail contained an eleven basepair consensus 
motive 5’-WTTTAYRTTTW-3’ in the A element, the mutation of which lead to the 
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complete loss of origin function. Introducing mutations in the B1, B2 and B3 sequences 
only caused a reduction in origin activity, and later studies found that most ARS 
sequences of the budding yeast genome are missing some of their B elements (Rao et al. 
1994; Lee & Bell 1997; Marahrens & Stillman 1992). 
Schizosaccharomyces pombe, another yeast species used as model organism, already 
differs from cerevisiae as it does not have ARS motif consensus sequences. Instead it 
uses 500-1000bp long AT rich stretches of DNA, which were found with the same 
method as the ARS sequences in budding yeast. S. pombe origins, like metazoan origins, 
do not have consensus sequences, however they often contain stretches of pure A or T, 
and are located in intergenic regions (Dai et al. 2005; Clyne & Kelly 1995). 
In metazoans, replicators are even less defined. In Drosophila and humans, any DNA 
sequence is able to recruit the initiator complex (Vashee et al. 2003; Remus et al. 2004). 
Also, plasmids containing random eukaryotic sequences larger than 5kb, and having a 
size greater than 15kb are able to replicate in human cells as evidenced by both short- and 
long-term plasmid maintenance assays (Heinzel et al. 1991; Krysan et al. 1993). Despite 
this fact, initiation events in the human genome are not random. As estimated, 
approximately 30.000 origins are activated during each cycle in human cells (Nasheuer et 
al. 2002; Aladjem 2007). However, the number of potential origins is estimated to be 
significantly higher, and from this pool of potential start sites only a subset is activated 
during each replication. A study published by my group shows that AT content, 
nucleosome density, MNase sensitivity and epigenetic marks all contribute to regulating 
where replication starts (Papior et al. 2012; Cayrou et al. 2011). This makes it difficult to 
adapt the replicon model to metazoans, as replicator elements are not defined by 
sequence, are not necessarily activated during each division, instead of discrete loci they 
can form initiation zones, and finally replicon sizes and locations vary between divisions 
(Schepers & Papior 2010). 
2.1.1.2 The initiator 
Replicators presented in the previous chapter are responsible for pinpointing future sites 
of replication initiation. Initiators are the trans elements needed to trigger the initiation 
event. 
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In bacteria, activation commences with dnaA proteins attaching to the 9-mer sequences, 
bending the origin DNA in the process. This allows the dnaB helicase to bind to the 13-
mers, along with its cofactor, dnaC. The helicase encircles single stranded DNA, 
therefore two units are loaded - one on each strand - allowing bidirectional replication at 
the oriC locus. As the helicase further opens up the origin, the bacterial polymerase along 
with its primase is recruited. The latter, also called dnaG, synthesizes an RNA primer, 
which is required for the polymerase to function. Once the complete replisome is 
assembled, the origin fires and DNA synthesis initiates (Kaguni 2011). 
Archaea employ a different system, which resembles a simplified form of the eukaryotic 
initiation mechanism (Kelman & Kelman 2003). During the archaeal DNA replication 
initiation process, origins are first bound by origin binding proteins (OBP), which are 
homologous to the eukaryotic Orc1/Cdc6 (MacNeill 2001; Dueber et al. 2007). These 
allow the recruitment of minichromosome maintenance factors (MCMs), which form a 
double-hexamer at the origin site, and unwind DNA. Once the MCMs are loaded, the 
recruitment of single stranded DNA binding proteins is triggered, which stabilize the 
single DNA strands and act as a platform to recruit the multi-subunit polymerase-primase 
complex. The entire process is similar to that of eukaryotes, but it is simpler and involves 
fewer elements. Interestingly, the number of OBP genes varies between different 
Archaea, whereas there are always six subunits of it in Eukarya (Myllykallio & Forterre 
2000). Similarly, MCM genes may have 1-4 copies in Archaea, but assemble into a 
double hexameric complex like the six distinct subunits of eukaryotes (Tye 2000). 
Eukaryotes have developed an even more sophisticated initiator system based on the 
principles established in Archaea. Briefly, replicators are first recognized by the six-
subunit origin recognition complex (ORC). Once ORC has assembled on DNA, it recruits 
Cdc6, Cdt1 and the MCM2-7 proteins to form the pre-replication complex (pre-RC) (Bell 
& Dutta 2002). The MCM2-7 proteins form head-to-head double hexamers like their 
counterparts in Archaea, and are also required to melt the DNA for the replication 
machinery (Evrin et al. 2009; Remus et al. 2009). Once the pre-RC is established, it 
further develops into the pre-initiation complex (pre-IC) by the addition of MCM10, 
Sld2, 3, 7 proteins, the GINS complex and Cdc45. This assemblage is finally able to 
attach the polymerase to initiate replication (MacNeill 2010; Takisawa et al. 2000). 
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This thesis deals with the role of the smallest subunit of ORC, Orc6. In order to 
understand its role in replication initiation, the origin recognition complex and eukaryotic 
replication initiation is introduced in more detail. 
2.2 The Origin Recognition Complex 
protein family 
The first eukaryotic initiators were identified in 1992 while conducting DNaseI 
footprinting experiments on ARS1 sequences in S. cerevisiae (Bell & Stillman 1992). It 
was found that a protein complex of six subunits binds specifically to ARS. This was 
named the origin recognition complex (ORC), and the six subunits were labeled Orc1-6 
in the order of their sizes, with Orc6 being the smallest subunit of 50 kilodaltons. Shortly 
after this discovery, the genes corresponding to each subunit were identified, and were 
found to be located on separate chromosomes (Li & Herskowitz 1993; Bell et al. 1993; 
Foss et al. 1993; Bell et al. 1995). Using these sequences it was quickly established that 
ORC components are highly conserved in all eukaryotes, and are key factors of 
replication initiation from yeast to man. 
Five of the six subunits have similar structures, the exception being Orc6, which is unlike 
any other member of the complex. Interestingly, the large, conserved consensus domain 
of Orc1-5 is also present in the Cdc6 protein, another prominent member of the pre-
replication complex. This indicates that these six proteins are paralogs (Duncker et al. 
2009). 
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Figure 2. Comparison of domains for Orc1-5 and Cdc6 from S. cerevisiae. Each of the six proteins 
depicted and labeled on the left are crucial for replication initiation. ORC proteins form a steady complex at 
origins, to which Cdc6 is promptly recruited in G1. The similar motifs found in all members are presented 
in orange, and are named the ORC/Cdc6 domain. This contains the AAA+ type ATPase domain and a 
winged helix responsible for DNA binding. The purple marks indicate the consensus Walker A and B, and 
Sensor 1 and 2 motifs of the ATPase domain, as well as the AT hook found in ScOrc2. The ATPase 
domain is complete in Orc1, Orc2, Orc5 and Cdc6, while being less conserved in Orc3 and Orc4 based on 
studies in yeast. Orc1 also contains a Bromo-adjacent-homology (BAH) domain which is used in 
heterochromatin formation. Orc6 is not depicted as it does not share any similar domains with any other 
ORC components. (image from: Duncker et al. 2009). 
The conserved ORC/Cdc6 domain contains an AAA+ type ATPase domain and a winged 
helix domain, as presented in Figure 2. ATPase activities of the different subunits vary 
among eukaryotes, but it is generally observed that ATP binding, but not hydrolysis is 
required for complex assembly and DNA binding. While Orc1, 4 and 5 have recognizable 
AAA+ sites, Orc2 and 3 only structurally resemble this motif. The most active subunit in 
this respect is Orc1, which binds ATP upon DNA attachment in yeast, Drosophila and 
humans, but its hydrolysis only occurs after Cdc6 recruitment to attach this factor to 
DNA. Cdc6 ATP hydrolysis is also required for this step (Speck et al. 2005; Chesnokov 
et al. 2001; Vashee et al. 2003). The presence of nucleotides is essential for complex 
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formation when using purified human proteins, but here ATP hydrolysis does not occur 
(Ranjan & Gossen 2006; Siddiqui & Stillman 2007). Orc5 was also observed binding 
ATP in yeast, but it does not hydrolyze it, whereas this ability is not a requirement in 
Drosophila (Klemm et al. 1997). 
The winged helix motif, the other conserved feature in the ORC/Cdc6 domain is required 
for DNA binding. This helix-turn-helix type domain is found in all known ORCs, 
however, binding characteristics are diverse among eukaryotes. For example, S. 
cerevisiae ORC recognizes ARS DNA, the AT hook of Orc4 in S. pombe prefers AT 
stretches, and metazoan ORCs bind any DNA sequence as discussed in chapter 2.1.1.1. 
(Tada et al. 2008). Although both the AAA+ and the winged helix domains are able to 
function on their own, they are likely to act in concert when the origin recognition 
complex is assembled.  
The architecture of eukaryotic ORCs has been studied using archaeal, yeast and human 
proteins. The archaeal Orc1/Cdc6 protein first forms a dimer after which it is able to 
recognize DNA with its winged helix, and stabilize the interaction by inserting a helix-
turn-helix motif from its AAA+ domain into the minor groove. DNA is bent, twisted and 
melted in the process (Gaudier et al. 2007; Dueber et al. 2007). In eukaryotes, the six 
subunit complex forms a ring-like structure in solution in yeast, and with the addition of 
Cdc6, the complex contains six AAA+ motifs, which loosely resembles the MCM- and 
replication factor C complexes (Speck et al. 2005). This assemblage also bends DNA 
upon attachment (Sun et al. 2012; Lee & Bell 1997). Using Drosophila ORC it was 
further elucidated that Orc1-5 form a right handed helical core with their AAA+ domains, 
which corresponds well to the bacterial dnaA complex that twists the origin (Clarey et al. 
2006).  
Although no crystallization study using human proteins has been published to date, the 
combination of biochemical analyses with the knowledge gained from yeast and 
Drosophila structures allows determining the organization of subunits within this 
complex as well. It has been elucidated that in humans, Orc2 and 3 form a very strong 
complex early on, to which first Orc5, then Orc4 attaches with high affinity (Ranjan & 
Gossen 2006; Siddiqui & Stillman 2007; Vashee et al. 2001; Kneissl et al. 2003). Orc4 
recruitment is dependent on the presence of ATP or ATPγS (a slowly hydrolyzing form 
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of ATP), which indicates that ATP binding, but not hydrolysis is required for this step. 
Thus, Orc2-5 form a stable core complex in humans to which Orc1 and Orc6 attach with 
low affinity (Dhar et al. 2001a; Saha et al. 1998). The core complex has been purified 
from human cells by the studies above, but they always found that Orc1 and 6 were only 
co-purified in sub-stoichiometric amounts. Orc1 attachment again requires the presence 
of ATP, which is in line with the DNA binding studies of ORC performed in yeast. 
According to the current models, the recruitment of Orc6 is less understood, but one 
study indicates that either Orc2-5 or Orc1-5 is able to bind Orc6 after localizing 
independently into the nucleus (Ghosh et al. 2011). 
2.2.1 ORC6  
Although the assembly and DNA binding of ORC have been extensively studied, there is 
surprisingly little data available on its smallest subunit, Orc6. Interestingly, this protein is 
unlike any other member of its family, being different in both structure and function 
(Duncker et al. 2009). It is a protein essential for life in all eukaryotes, it is involved in 
replication, but its exact role remains unclear. 
Shortly after the discovery of ORC in yeast, it was established that Orc6 is not required 
for ORC-DNA interaction of S. cerevisiae ORC (Lee & Bell 1997; Li & Herskowitz 
1993). Surprisingly, later it was shown that it is essential for the same step in Drosophila 
(Chesnokov et al. 2001). The same year it was also found that in vitro replication using 
the cell-free Xenopus replication system is functional in the absence of Orc6 (Gillespie et 
al. 2001), however this study only assayed the presence of ORC components via low 
sensitivity visualization techniques (Coomassie stains), therefore the small Orc6 protein 
present in sub-stoichiometric amounts might have evaded detection. Also, the Xenopus 
Orc6 homologue was not even identified at that time (Klein et al. 2002; Giordano-Coltart 
et al. 2005). 
Orc6 was also not instantly identified in humans, due to it being less conserved than the 
other members of its family (Dutta & Dhar 2000; Duncker et al. 2009). So far there is no 
clear answer to why Orc6 is evolving faster than all the other ORC components. 
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Structurally, Orc6 does not contain any identified conserved domains, which are present 
in all eukaryotes. The sole ‘Orc6 domain’, which fills most of the human protein 
sequence, has no defined function, but serves as a tool to identify homologues in other 
species. Human Orc6, but not that of S. cerevisiae has two disordered regions, which are 
separated by a putative coiled coil motif. A similar motif in Drosophila Orc6 interacts 
with Pnut, a Drosophila septin protein (Chesnokov et al. 2003). This region also contains 
the nuclear localization signal (Ghosh et al. 2011). 
Only a part of HsOrc6 has been crystallized. The region between amino acids 94 and 187 
forms a globular domain containing six helices (Liu et al. 2011). The resulting structure 
in Figure 3B resembles the transcription factor TFIIB. This factor in concert with the 
TATA box binding protein is an important transcriptional regulator. Based on this, Orc6 
interacting with other co-factors is likely to attach to DNA to function. The DNA binding 
characteristics imply an innate binding activity with no preference for human Orc6 for 
any sequence. Footprinting experiments confirmed that human Orc6 equally protects the 
entire target strand, and it even binds single stranded DNA, similarly to yeast (Lee et al. 
2000). 
As depicted in Figure 3C, the position of Orc6 within yeast ORC is predicted to be in the 
vicinity of Orc2 and 3. HsOrc6 and MmOrc6 bind weakly to Orc2 and 3, however in 
yeast, only its interaction with Orc2 is found. It is also able to pull down a part of the 
Orc1 protein, but not the entire subunit (Lee & Bell 1997; Vashee et al. 2001; Sun et al. 
2012; Kneissl et al. 2003). Apart from ORC, other pre-RC factors were also found to 
interact with Orc6, namely Cdc6 (Thomae et al. 2011); and Mcm5, Dbf4, Cdc7, Cdc45, 
RPA70, RPA14 in an extensive interaction screen using mouse proteins in yeast (Kneissl 
et al. 2003). The nature of these interactions is yet to be clarified, but it has already been 
observed in yeast that Orc6 tethers Cdt1 to ORC, which subsequently allows MCM 
complex recruitment and pre-RC formation (Chen et al. 2007; Chen & Bell 2011). 
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A) 
 
B)      C) 
 
Figure 3. Overview of the human Orc6 protein. A) Amino acid sequence of HsOrc6 and main features. 
The area homologous to the Drosophila DNA binding domain (DBD) is shown in blue, with S72 and K76, 
the two essential amino acids for DNA binding in Drosophila, highlighted. The amino acids marked in red 
correspond to the most prominent secondary modification sites so far detected by high throughput studies 
(11 other sites with only a single detection are not shown). Of these sites, only T195, a known CDK1 
target, has been experimentally validated (Ghosh et al. 2011). The nuclear localization signal (NLS) is 
depicted in orange, while the green helices labeled α1-6 correspond to the structures seen in the crystallized 
middle domain of HsOrc6 shown in B) (image from: Liu et al. 2011). The three amino acids marked in 
green are crucial for DNA binding of HsOrc6. C) Presents the cryo-EM structure of S. cerevisiae ORC with 
the putative position of Orc6 in red (image from: Sun et al. 2012). 
DBD α1 α2
α3 α4 α5 α6
NLS
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Going a step further, Orc6 has been postulated to interact prominently with other, non-
pre-RC factors even upon its discovery. The initial Orc6 study in humans found that the 
protein was able to pull down several unknown factors (Dutta & Dhar 2000). Other 
studies later found that HsOrc6 also interacts with Cdk1 and HMGA1a (Ghosh et al. 
2011; Thomae et al. 2008). 
The former is an important regulator of cell cycle control, and phosphorylates both Orc2 
and Orc6 in yeast. This event is mediated by Clb5 binding to an RXL motif to ScOrc6, 
which blocks one of the two Cdt1 interactions sites and so abolishes MCM complex 
loading. Mutation of this site to a constantly dephosphorylated form induces re-
replication (Chen & Bell 2011; Wilmes et al. 2004). To the contrary, in HsOrc6, the 
Cdk1 site (T195) is within the nuclear localization signal, and microscopy studies 
confirmed that only the phosphorylated form of the protein is able to enter the nucleus, 
while the dephosphorylated form stays cytosolic (Ghosh et al. 2011). Therefore Cdk1 
phosphorylation of Orc6 is crucial for replication initiation in humans. 
Apart from its replication function, it is also emerging that ORC proteins are involved in 
processes not related to pre-RC formation (Thome et al. 2000; Scholefield et al. 2011). 
Specifically, a role for HsOrc6 and DmOrc6 during mitosis and cytokinesis is presented 
by recent studies (Prasanth et al. 2002; Huijbregts et al. 2009; Bernal & Venkitaraman 
2011). These show that DmOrc6 interacts via its C terminus with Pnut, a Drosophila 
septin protein. Also, HsOrc6 localizes to the midbody during cytokinesis, and it also 
interacts with the kinetochore. In yeast, Orc6 depletion reduces MCM2-7 loading and 
disturbs S phase entry, but has no effect on mitosis - whereas in Drosophila and humans, 
aside from decreased replication, a mitotic defect is most prominent upon Orc6 depletion 
(Semple et al. 2006; Balasov et al. 2009). 
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2.3 Initiation of replication in human 
cells 
To place the function of ORC in context, the process of DNA replication initiation has to 
be looked at in more detail. As ORC itself, this process is highly conserved among 
eukaryotes, with only minor differences between species. Most of our knowledge on it 
comes again from the budding yeast S. cerevisiae, which is supplemented by studies in 
higher eukaryotes. 
Preparation for the upcoming replication cycle already begins at the end of mitosis. In 
late M phase and early G1, ORC takes the first step in replication by binding origin DNA. 
In S. cerevisiae and S. pombe it does not even dissociate from DNA and stays chromatin 
bound throughout the cell cycle (Ogawa et al. 1999; Aparicio et al. 1997). In higher 
eukaryotes, there is contradicting evidence as to how ORC attaches to chromatin. In 
frogs, initial studies found that ORC is at least partly removed from chromatin during 
mitosis (Romanowski et al. 1996), although other studies speculate this observation to be 
an artifact (Bell & Dutta 2002). It is more apparent from studies in hamster- and human 
cells that Orc1 dissociates from ORC during mitosis, only to be re-recruited in the next 
cycle (Kreitz et al. 2001; Natale et al. 2000; Li & Jin 2010; Gerhardt et al. 2006).  
Regardless of ORC assembly, eukaryotic replication pathways converge on the point 
where ORC is successfully assembled on chromatin in the G1 phase of the cell cycle. 
Once this has been accomplished, it serves as a platform for pre-RC formation. It is 
important to note that only a subset of ORCs continue on to build pre-replication 
complexes, the exact selection criteria being unknown to date (Schepers & Papior 2010). 
The subset of ORCs that do continue in replication initiation first bind the Cdc6 protein. 
As seen in chapter 2.2, Cdc6 belongs to the same protein family as Orc1-5 and acts in 
concert with them in replication initiation. In yeast, Cdc6 is even able to interact with 
ORC in solution, but this is yet to be analyzed in higher eukaryotes (Sun et al. 2012).  
Next, the ORC-Cdc6 complex recruits the Cdt1-MCM2-7 group. Cdt1 is a key regulator 
of pre-RC formation and a preventer of re-replication. It is required for the recruitment of 
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MCM components to origins and for promoting the formation of the heterohexameric 
MCM complex. In yeast it was even observed binding to MCM components and being 
transported to the nucleus together (Tanaka & Diffley 2002; Wu et al. 2012). MCM2-7 
recruitment itself is the hallmark of pre-RC formation and the key step in replication 
initiation. MCM2-7 form the motor domain of the replicative helicase in eukaryotes, and 
are therefore crucial for replication fork progression during S phase. The six MCM 
components (MCM2-7) assemble into a ring-like structure and attach to chromatin in a 
two-step process. This ‘lock and load’ mechanism first recruits the MCM complex to 
ORC bound origins, and then loads it onto chromatin so that the MCM ring encircles 
DNA. As a review on the topic states: “The temporal separation of helicase loading and 
activation is crucial for the coordination of DNA replication with cell growth and 
extracellular signals, the prevention of re- replication and the control of origin activity in 
response to replication stress” (Remus & Diffley 2009). 
During this step, the preassembled MCM rings attach to the ORC-Cdc6 complex with the 
aid of Cdt1 (Seki & Diffley 2000). Then, taking two hexamers head to head, a 
dodecameric MCM complex is loaded onto DNA in an ATP dependent manner (Sclafani 
et al. 2004). Since replication initiation is bidirectional at most origins, it is postulated 
that at least two such dodecamers are loaded up at each site (Soultanas 2012). However, 
since loaded MCM rings can slide on DNA, multiple such complexes are able to get 
established at a single origin site. MCM loading, but not ORC and Cdc6 binding is 
abolished in the presence of ATPγS. Because of this, it was postulated, and recently 
proven, that ORC ATP hydrolysis is required for MCM loading (Machida et al. 2005; 
Fernández-Cid et al. 2013).  
Once ORC, Cdc6, Cdt1 and the MCM complexes are loaded onto DNA, the pre-RC is 
complete. After passing the restriction point at the end of G1, the pre-replication complex 
develops into the pre-initiation complex (pre-IC), and the role of ORC becomes less 
crucial. Recent studies even found diminishing ORC levels after MCM loading 
(Tsakraklides & Bell 2010; Kundu et al. 2010; Arias & Walter 2007). The recruitment of 
MCM10, Cdc45 and the GINS complex, coupled to CDK and DDK (Dbf4 dependent 
kinase) activity prepares the origin site to load the single strand binding proteins, and 
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finally the polymerase-primase complexes (Sheu & Stillman 2006). Upon entering S 
phase, the origin fires and DNA replication initiates (Bell & Dutta 2002). 
Attempts have been made at reconstructing replication complexes in vitro. S. cerevisiae, 
the most well-studied model organism for replication, has proven to be the most 
successful environment for such studies. Using purified ORC, Cdt1, Cdc6 and MCM 
subunit, MCM complexes load onto DNA and complete pre-RCs are assembled in vitro 
(Kawasaki et al. 2006). This method is a robust tool to study pre-RC formation in yeast 
(Remus et al. 2009; Mehanna & Diffley 2012; Evrin et al. 2009; Heller et al. 2011). In 
metazoans, an assay using Xenopus egg extracts was also created (Gillespie et al. 2001; 
Gambus et al. 2011; Waga & Zembutsu 2006). This is the only vertebrate based system 
to date capable of creating functional pre-RCs in vitro in a cell free manner. Interestingly, 
the Xenopus system is even able to function if XlORC is replaced with recombinant 
HsORC (Vashee et al. 2003; Giordano-Coltart et al. 2005). Although a human in vitro 
replication system using intact nuclei and cytosolic extracts also exists, this system lacks 
flexibility due to the need for complete nuclei (Krude 2006; Baltin et al. 2006). 
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2.4 The Epstein-Barr virus genome as 
model for human DNA replication 
The processes described in the previous chapter have proven to be challenging to analyze 
in humans. The vastness of the human genome coupled to the amazing flexibility of 
origin activation and the complexness of chromatin have hindered the thorough analysis 
of replication initiation in vivo (Schepers & Papior 2010). To circumvent this problem, I 
took advantage of the Epstein-Barr virus latent DNA replication system. This allows 
observing replication initiation inside human cells, but instead of the complicated host 
chromosomes, the more well understood and simpler EBV genome is studied. 
This virus and its 163kb circular, double stranded genome have been thoroughly studied 
for its pathogenicity, as well as its capability to establish a life-long latent infection 
(Young & Rickinson 2004; Babcock et al. 1998). To achieve this EBV uses a well-
studied latent program (Takacs et al. 2010). This is centered on the function of the 
Epstein-Barr virus nuclear antigen 1 protein (EBNA1), which has a dual role in EBV 
latent replication. First, EBNA1 is able to recruit the pre-RC machinery, most notably 
ORC, to oriP, the latent origin of replication of the viral genome. With this EBNA1 
establishes a de novo origin of replication at oriP (Schepers et al. 2001; Ritzi et al. 2003; 
Norseen et al. 2008; Wang & Sugden 2005; Lindner et al. 2008; Chaudhuri et al. 2001; 
Dhar et al. 2001b). Secondly, EBNA1 tethers the EBV genome to the host’s 
chromosomes, distributing the viral genome equally among the daughter cells. This 
“piggyback” mechanism allows stable distribution of viral genomes which have no 
centromers on their own (Middleton & Sugden 1994; Smith & Sugden 2013; Marechal et 
al. 1999). 
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Figure 4. The Epstein-Barr virus genome. The 163kb double stranded DNA genome of the virus 
circularizes upon cell entry. In the latent phase, EBNA1 (blue arrow) and other latent proteins (shown in 
black) are expressed in the host to maintain a lifelong infection in human B cells. The latent viral origin of 
replication (oriP, red), responsible for the replication and retention of the latent EBV genome, consists of 
the dyad symmetry element (DS) and the family of repeats (FR) (image from Ravasz 2008). 
Interestingly, the two duties of EBNA1 are spatially separated within oriP. The origin 
consists of two main regions, the family of repeats (FR) and the dyad symmetry element 
(DS) (Hirai & Shirakata 2001). The former is strictly responsible for recruiting EBNA1 
to tether the viral genome to the host chromosomes; while the latter is used for EBNA1 
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dependent replication initiation, confirmed by ChIP experiments showing an 
accumulation of pre-RC components in G1 (Schepers et al. 2001). It is important to add 
that despite a prominent presence of pre-RC factors, replication initiation is distributed all 
over the EBV genome (Papior et al. 2012). 
2.4.1 Analyzing replication competence of proteins in vivo: the 
plasmid rescue assay 
The plasmid rescue assay is based on the function of oriP and EBNA1 outlined above 
(Thomae et al. 2011). It provides an important functional readout for this work, and is 
therefore presented here in detail. 
To study if a protein of interest can initiate replication, it needs to be directed to the DS 
element of an oriP containing plasmid in a cell. If it can initiate replication, then the 
plasmid will be maintained through multiple generations, but if not, then the plasmid will 
be eventually lost from the culture. To direct proteins of interest to DS, a fusion construct 
is generated by attaching the protein of interest to a targeting domain, such as a single 
chain Tet repressor (scTetR), or a Gal4 DNA binding domain. The former specifically 
binds to Tet operator sites (TetO) in the genome, while the latter attaches only to GAL4 
consensus sequences (Krueger et al. 2003). By replacing DS with either TetO or GAL4 
sites, the fusion protein is made responsible for replication initiation, while EBNA1, 
losing its binding sites in DS, will only attach to FR and ensure distribution. 
To carry out a plasmid rescue assay, human HEK-293 cell lines are generated first, which 
stably express EBNA1 and the fusion protein of interest. Also, plasmids are cloned that 
carry a eukaryotic and a prokaryotic selection marker, as well as either a wild-type oriP 
sequence or an FR-TetO construct. Next, the expression cells are transfected with either 
the wild-type oriP, the FR-TetO plasmid, or with water for control. After transfection the 
cultures are put under selection of the antibiotic to which the plasmid grants resistance. 
As soon as the water transfected cells die due to the toxic antibiotics, surviving cells are 
harvested. This is to ensure that all cells collected contain at least one copy of the 
transfected plasmid. 
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Harvested cells are then lysed using the HIRT protocol, a DNA isolation method that 
enriches for low molecular weight DNA, including plasmids, in the lysate. Once the 
DNA is isolated, it is digested with DpnI, a restriction enzyme specifically cutting non-
replicated plasmids carrying the Dam-methylation pattern, thus removing any original 
plasmids introduced during transfection. Since genomic DNA will still be in abundance 
in the purified samples, this serves as a type of loading control. Using the same amount of 
DNA for subsequent steps from the individual transfections ensures that the same amount 
of cells was used from each sample. Therefore a uniform amount of DNA from each 
HIRT extract is transferred into bacteria via electroporation, after which the transformed 
bacteria are distributed onto agar plates. Finally, the bacterial colonies appearing on the 
plates are counted. This is the readout of the experiment, and it gives valuable 
information about the ability of the fusion proteins of interest to initiate DNA replication. 
If a large number of colonies are observed in the FR-TetO transfection, it means that the 
fusion protein efficiently recruits the replication machinery to the plasmids, and these can 
steadily replicate, and then get distributed via FR and EBNA1 to the next generation of 
cells. If a small number of colonies are observed, then the fusion protein was not able to 
initiate replication efficiently, and only a few plasmids were replicated and distributed 
upon cell division. If the fusion is completely unable to facilitate replication, then either a 
very small number of colonies are counted, or the cells die out along with the water 
control, and are considered to provide zero colonies. 
Since different cell lines show slightly different growth characteristics, numbers of 
colonies for FR-TetO plasmids are always presented as percentage compared to wild-type 
oriP plasmids cultivated under similar conditions in parallel. 
With the procedure established and the necessary cell lines and plasmids created, it 
became possible to test Orc6’s ability to create functioning origins of replication in vivo.
3. Material and Methods 
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3.1 Material 
3.1.1 Oligonucleotides 
All the oligonucleotides listed here were synthesized by Metabion. 
 
Name Sequence 
102 Eag1_SG4_ORC6_T_forw ATATATCGGCCGGATCGGGCGGAGGTGGCAT 
103 Eag1_SG4_ORC6_50_T_forw CGGCCGTATCAGGAGGTGGTTGCCTGGACCTTGCAGCTTCCTGGATGAAG 
104 ORC6_200_stop_EcoR5_T_rev GATATCTTACACTATCTTCTTTCTCTTCCGTGGTGGAGTAGCTAC 
105 ORC6_253_stop_EcoR5_T_rev GATATCTTACTCTGCTGTAGCCTTTTGAGCACTGGCAGC 
106 primer_ORC6_dNLS_forw ACAACTAGAGATAGTGGTTGAAGCCCCAGCAAAG 
107 primer_ORC6_dNLS_rev CAACCACTATCTCTAGTTGTTTACACAGTCGATCAAA 
114 Nde1_start_SSF_Eag1_forw GAGAACATATGGACTACAAAGACGATGACGATAAATGGAGCCACCCGC
AGTTCGAAAAAGGTGGTTCCGGTGGATGGAGCCACCCGCAGTTCGAAA
AAGGGGGGGGCCGGCCGGT 
115 Nde1_start_SSF_Eag1_rev ACCGGCCGGCCCCCCCCTTTTTCGAACTGCGGGTGGCTCCATCCACC
GGAACCACCTTTTTCGAACTGCGGGTGGCTCCATTTATCGTCATCGTCT
TTGTAGTCCATATGTTCTC 
132 ORC6_253_BiFC_EcoR5_T_rev ATGATATCTTCTCTGCTGTAGCCTTTTGAG 
133 ORC6_200_BiFC_EcoR5_t_rev ATGATATCTTCACTATCTTCTTTCTCTTCCG 
161 pET SSF for TAGGATCCATGGACTACAAAGACGATGACG 
162 pET SSF rev ATCCCGGGCGGCCGGTCCCCCCCCTTTTTCG 
205 ORC6_50-125_for AGACCAGCAGTGCAGTCATGCCCCAGACACAGCAAGTGGA 
206 ORC6_125-204_for AAAGCTATGAGTCCAGTCTTGTTGAAGCCCCAGCAAAGGA 
207 ORC6_50-204_for AGACCAGCAGTGCAGTCATGGTTGAAGCCCCAGCAAAGGA 
208 ORC6_50-125_rev TCCACTTGCTGTGTCTGGGGCATGACTGCACTGCTGGTCT 
209 ORC6_125-204_rev TCCTTTGCTGGGGCTTCAACAAGACTGGACTCATAGCTTT 
210 ORC6_50-204_rev TCCTTTGCTGGGGCTTCAACCATGACTGCACTGCTGGTCT 
069-Pre-RC small oligo forw GAGTTCCAGACTATACCCAGAGTGTCCTAATGTCTG 
070-Pre-RC small oligo rev  CAGACATTAGGACACTCTGGGTATAGTCTGGAACTC 
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3.1.2 Plasmids 
The plasmids used throughout this work were either created by me or obtained from the 
Helmholtz Centre Munich, Hämatologikum plasmid bank. Here the plasmids are stored 
in E. Coli DH5alpha cells, in LB medium supplemented with 5% glycerol and stored at  
-80°C. From each strain plasmid preparation was performed as detailed in chapter 3.2.13 
before use. 
 
Name Main features 
pUC19 2686bp, amp  
pEPI-UPR 7211bp, amp, UPR (Schaarschmidt et al. 2004) 
pJET Clonejet kit, Thermo Scientific  
p4805  pBiFC flag-orc6-1-200-yfp-1-155 
p4806 pBiFC flag-orc6-50-253-yfp-1-155 
p4807 pBiFC flag-orc6-50-200-yfp-1-155 
p4808 pBiFC flag-orc6-S72A-K76A-yfp-1-155 
p4809 pBiFC flag-orc6-T195E-yfp-1-155 
p4810 pBiFC flag-orc6-dNLS-yfp-1-155 
p3652 pBiFC flag-orc6-wt-yfp-1-155 
p5412 pBiFC flag-orc6-d50-125-yfp-1-155 
p5392 pBiFC flag-orc6-d125-203-yfp-1-155 
p5393 pBiFC flag-orc6-d50-203-yfp-1-155 
p3736 pBiFC ha-orc2-wt-yfp-155 
p4068 pBiFC Fos 
p4069 pBiFC Jun 
p3725 RFP-PCNA 
p3230 wt oriP Hyg 
p3315 FR-4xTetO Hyg 
p3243 FR only, Hyg 
p5233 3230 with Gal4 
p5234 3315 with Gal4 
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p5235 pcDNA3-zeo-Gal4:PR-SET7 
p5237 pcDNA3-zeo-Gal4 
p4791 pET21 Orc6-1 (AA1-200) 
p4792 pET21 Orc6-2 (AA50-253) 
p4793 pET21 Orc6-3 (AA50-200) 
p4794 pET21 Orc6-4 (S72A K76A) 
p4795 pET21 Orc6-5 (T195E) 
p4796 pET21 Orc6-6 (no NLS) 
p4797 pET21 Orc6-7 (wild-type, full length) 
p4798 pWHE Sc-Tetr:Orc6-1 (AA1-200) 
p4799 pWHE Sc-Tetr:Orc6-2 (AA50-253) 
p4800 pWHE Sc-Tetr:Orc6-3 (AA50-200) 
p4801 pWHE Sc-Tetr:Orc6-4 (S72A K76A) 
p4802 pWHE Sc-Tetr:Orc6-5 (T195E) 
p4803 pWHE Sc-Tetr:Orc6-6 (no NLS) 
p4804 pWHE Sc-Tetr:Orc6-7 (wild-type, full length) 
3.1.3 Antibodies 
Primary antibodies 
 
Name Species Dilution Source 
Orc6 3A4 rat 1:50 Kremmer, E, (Ritzi et al. 2003) 
Orc1 rabbit 1:400 Santa Cruz Biotech (H-80) 
Orc2 rabbit 1:1000 (Papior et al. 2012) 
Orc3 rabbit 1:1000 (Schepers et al. 2001) 
Orc4 mouse 1:4000 Transduction Laboratories (#83120) 
Orc5 rabbit 1:4000 purified, lab stock 
Cdt1 rabbit 1:0000 gift from the Knippers laboratory 
Cdc6 mouse 1:400 Santa Cruz Biotech (180.2) 
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Mcm2 rabbit 1:1000 purified, lab stock 
Mcm3 rabbit 1:1000 (Ritzi et al. 2003) 
Mcm5 rat 1:1 3F3, 2F3 Kremmer, E 
Gal4 rabbit 1:400 Santa Cruz Biotech (sc-577) 
TetR rabbit 1:2000 gift from the Behrens laboratory (SA-1851) 
Pr-Set7 rabbit 1:2000 Julien, E (Cell Signaling C18B7) 
HA rat 1:50 3F10 Kremmer, E 
FLAG mouse 1:1000 Sigma M2 
EBNA1  rat 1:50 1H4 Kremmer, E (Grässer et al. 1994) 
 
Secondary antibodies 
 
Name Species Dilution Source 
anti-rat-HRP goat 1:10000 BD-biosciences  
anti-rabbit-HRP goat 1:10000 Promega 
anti-mouse-HRP goat 1:10000 Promega 
anti-rat-cy3 goat 1:200 Life Technologies 
anti-mouse-cy5 goat 1:200 Life Technologies 
3.1.4 Bacterial strains 
Name Source 
E. coli DH5alpha lab stock (Hanahan 1983) 
E.coli DH10B (electromax) Life Technologies 
E. coli Rosetta pLysS lab stock 
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3.1.5 Cell lines and culture material 
The following cell lines were taken from the Helmholtz Centre Munich cell culture 
stocks: RAJI, HeLa, HeLa S3, HepG2, HEK-293-D, HEK-293 EBNA1
+
.  
All other cell lines used throughout this work were established by myself as detailed in 
chapter 3.2.2, namely: HEK-293 EBNA1
+
 wt Orc6
+
, HEK-293 EBNA1
+
 ΔC Orc6+, 
HEK-293 EBNA1
+
 ΔN Orc6+, HEK-293 EBNA1+ ΔCN Orc6+, HEK-293 EBNA1+ S72A 
K76A Orc6
+
, HEK-293 EBNA1
+
 T195E Orc6
+
, HEK-293 EBNA1
+
 ΔNLS Orc6+, HEK-
293 EBNA1
+
 Orc6 PR-Set7
+
. 
 
Name Source 
Culture dishes (bottles, six well, 6cm, 15cm) Sigma-Aldrich (Nunclon) 
Cryotubes Sigma-Aldrich (Nunclon) 
DMEM medium Life Technologies 
Fetal Calf Serum (FCS) Life Technologies 
HEPES Life Technologies 
Hygromycin Life Technologies 
Lipofectamine Life Technologies 
Neomycin (G418) Life Technologies 
Opti-MEM medium Life Technologies 
Pen-Strep Life Technologies 
RPMI 1640 medium Life Technologies 
Trypsin-EDTA Life Technologies 
Zeocine Life Technologies 
 
  
Material and Methods 
 
 
- 34 - 
3.1.6 Software 
Function Provider 
Cell line database Filemaker Pro 
DNA sequence analysis and in silico cloning Macvector 
Lab books Google docs, MS Office 
Functional clustering DAVID, STRING 
Microscopic image processing, image quantification ImageJ 
Proteomics Scaffold 4 
Sequence alignment BLAST 
3.1.7 Equipment and other material 
Material not listed here was procured from Merck. Chemicals were regularly of pro 
analysi grade. 
 
Material Provider 
Avanti J10, J25 centrifuge, L7-55 Ultracentrifuge Beckman Coulter 
Gene-Pulser II, 10ml columns Bio-Rad  
Ultrasound sonifier Branson 
PAA, SDS, Phenol, Spectra-Por 6 Dialysis membrane Carl Roth 
Bacto-Agar, Yeast extract, Trypton Difco 
Reaction tubes, Table top centrifuge 5415, 
Spectrophotometer, PCR machine Mastercycler personal 
Eppendorf 
Cover slip, Whatman paper, X-ray film Hartenstein 
JetStar Maxiprep kit Genomed 
Hybond ECL membrane, Protein A Sepharose GE healthcare 
Semi-Dry Blotting System Hoefer 
Strep-Tactin protein purification kit IBA 
Benchmark protein ladder, not prestained, dynabeads, 
Qubit fluorometer, Colloidal Blue staining kit 
Life Technologies 
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Leica TCS SP5 Confocal-microscope Leica 
Nucleospin Gel and PCR clean-up kit Macherey-Nagel 
Restriction enzymes and buffers, Pwo polymerase,  New England Biolabs 
Electrophoresis chamber, electroporation cuvette Peqlab 
Qiaquick PCR purification kit Qiagen 
dNTPs, Tris, DNase I, RNase A, cOmplete (EDTA free) Roche 
Ampicillin, Bromophenol blue, DMSO, DTT, Glycine, 
HEPES, Triton X-100, Tween-20, BSA, Benzonase, MG132 
Sigma-Aldrich 
Spectra-Por dialysis membrane Spectrum Labs 
Robocycler Stratagene 
Generuler 1kb DNA ladder Thermo Fisher Scientific 
7ml Douncer Wheaton 
Vectashield, Photoprobe (S-S) biotin Vector Labs 
Axiovert 10 fluorescence microscope Zeiss 
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3.2 Methods 
3.2.1 Cell cultivation 
All human cells used in this study were cultivated in incubators set at 37°C and 5% CO2.  
 
HeLa 
I raised adherent HeLa cells in RPMI medium with 10% FCS and 1% Pen-Strep in 15cm 
culture dishes. I monitored the density of the cells and at 80% confluency I diluted the 
culture fivefold. To achieve this, I removed the medium, and washed the cells once in 
sterile PBS. Afterwards, I applied 2ml trypsin (0.05% Trypsin-EDTA) solution to the 
cells until they detached from the surface or for maximum 5 minutes. Next, I added 2ml 
medium and resuspended the cells using a pipette. From the resulting 4-5ml solution, I 
added 20% to a new plate and supplemented it with 20ml fresh medium. 
 
HeLa S3 
Suspension HeLa cells (HeLa S3) were cultivated in 1L roller bottles, with conditions 
similar to semi-adherent cells. Density was measured via using a Neubauer cell counting 
chamber and kept between 2-8 x 10
5
 cells / ml. 
 
HEK-293 and HepG2 
I cultured HEK-293 and HepG2 cells and their derivatives in DMEM medium with 10% 
FCS and 1% Pen-Strep in 15cm culture dishes. I diluted the cultures similarly to HeLa 
cells. I cultured HEK-293 EBNA1
+
 cells using 220ng/μl G418, HEK-293 EBNA1+ Orc6+ 
cells using 300ng/ml puromycine and HEK-293 EBNA1
+
 Gal4
+
 (PR-Set7
+
) constructs 
with 10μg/ml zeocine. 
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3.2.2 Transfection of human cells 
For creating HEK-293 EBNA1
+
 cells expressing Orc6 variants, Gal4, and PR-Set7, I 
transfected cells as follows. The day before transfection I seeded 1.5 x 10
5
 cells into each 
well of a six well plate. The next day, I exchanged the medium to FCS free medium 
before transfection. Meanwhile, I digested 3μg of the expression plasmid using a 
restriction digest to linearize the plasmid, and supplemented it with opti-MEM medium to 
achieve a 50μl / sample volume. I added Lipofectamine transfer reagent (cat. no. 11668-
027, 2μl/μg plasmid) to opti-MEM medium in a separate container in 50μl / sample 
volume and left the solutions standing on room temperature for 5 minutes. Afterwards I 
mixed the lipofect solution with the plasmid solution to reach 100μl / sample volume and 
lipid spheres encompassing linear plasmids were left forming for 20 minutes room 
temperature. Next, I added the ready solution in a careful drop-by-drop manner to the 
seeded cells and then left them for 4 hours in the incubator for the transfection process to 
complete. Following this, I added fresh medium to the cells and they were left in the 
incubator overnight. The next day I introduced selection pressure as presented in the 
previous chapter. After single-cell colonies formed on the plates under selection pressure 
(2-3 weeks), I picked the colonies using a piece of sterile paper soaked in trypsin and 
transferred them to six well plates. I tested the cultures resulting from the single cell 
colonies for expression by making RIPA extracts, and using these for immunoblotting. 
3.2.3 Plasmid-rescue assay 
I performed plasmid rescue assays using HEK-293 EBNA1
+
 cells and their derivatives. 
First, I transfected the cells as described in the previous chapter until the point where they 
were placed under selection using 80μg/ml Hygromycin. Hygromycin selection seemed 
more efficient after the first splitting of cells, and was best when cells were kept at low 
confluency. I kept the cells in logarithmic growth phase until the water transfected 
control died out under selection (approx. 2 weeks). Then, I washed full plates of the 
transfected cells once with TEN buffer (10mM Tris-HCl pH 7.5, 1mM EDTA, 150mM 
NaCl) and lysed them by adding 1.5ml TEN and 1.5ml 2x HIRT lysis buffer (1.2% SDS, 
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20mM Tris pH 7.5, 20mM EDTA). The resulting lysates were collected using a glass 
slide into a centrifuge tube and supplemented with 750μl 5M NaCl. The samples were 
then purified via phenol-chloroform extraction (Chomczynski & Sacchi 1987). I 
subjected the clean DNA samples to Dpn1 digest by adding 11μl NEB4 restriction 
enzyme buffer, 3µl Dpn1 (20U/µl), and 3µl RNase and incubated them for 2 hours at 
37°C to remove RNA and unreplicated plasmid DNA. This was followed by an ethanol 
precipitation by adding 20μl 3.5M NaAc, 400μl 100% Ethanol, incubating for at least 1 
hour at -20°C, centrifuging 1 hour at 4°C, 16K g, discarding the supernatant and washing 
once with 500μl 70% ethanol, centrifuging once more for 15 minutes at 4°C, 16K g, then 
discarding the supernatant, air drying and finally resuspending in 50μl dH2O. 
Then, I assayed the ready, clean DNA samples containing the rescued plasmids using the 
Qubit fluorometer’s broad range DNA measurement kit according to the manufacturer’s 
instructions. 
From the measured samples, I introduced 100ng DNA into Electromax DH10B bacteria 
via electroporation with a Bio-Rad Genepulser with a resistance of 200 Ω, capacitance of 
25μF, voltage set to 2.5 kV and using the manufacturer’s instructions. 
Transformed bacteria were plated onto agar plates with 100μg/ml ampicillin and stored 
overnight in an incubator at 37°C. Next day I counted the colonies on each plate. 
3.2.4 Fluorescence Microscopy 
To visualize the location of specific proteins in the cell, I employed fluorescence 
microscopy. For this, HepG2 cells were transfected similarly to HEK-293 cells as 
described in chapter 3.2.2, but instead of selecting the cells for 3 weeks, I carried out the 
following protocol after 36 hours of expression. 
I washed the cells twice with PBS and fixed them with 2% Formaldehyde in PBS for 10 
minutes at room temperature. Then, I carefully washed them twice with PBS, placed 
them on ice and gently lysed them with 0.5% Triton X-100 in PBS for 5 minutes. 
Blocking was performed by adding 1% BSA and 0.15% Glycine in PBS for 10 minutes at 
room temperature. Afterwards, I applied 80μl primary antibody in 2% BSA in PBS (rat 
anti-HA 1:10 for Orc2 and mouse anti-FLAG 1:300 for Orc6) to the sample and 
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incubated it for 1 hour at room temperature; or overnight at 4°C. After this I washed the 
cells twice for 5 minutes with PBS. Next, I added 80μl of the secondary antibody (anti-rat 
Cy3 and anti-mouse Cy5) in a 1:200 dilution using 2% BSA solved in PBS and incubated 
it 1 hour at room temperature. Following this, I performed DAPI staining by adding 80μl 
of 1:20 000 diluted 5mg/ml DAPI in PBS to the sample and incubating it for 15 minutes 
at room temperature. After three washes with PBS, I placed the cover slips containing the 
prepared cells face-down in 8μl Vectashield, and sealed them with nail polish. 
3.2.5 Protein extract preparation 
RIPA Extract 
This protocol was used for fast, complete lysis of cells. First, I removed medium from an 
80% confluent 15cm culture dish containing approximately 2x10
6
 cells and washed them 
in PBS. After that the cells were detached from the plate by adding 2ml trypsin which I 
neutralized with 2ml medium once the process was complete. I then transferred the 
solution containing the cells to a 15ml Falcon tube and centrifuged it for 10 minutes at 
1000rpm, 4°C. After removing the supernatant, I resuspended the pellet in 400ul RIPA 
buffer (50mM Tris-HCl pH 8.0, 150mM NaCl, 0.1% SDS, 0.5% DOC, 1% NP-40 with 
1x cOmplete-EDTA free). After transferring the solution to a 1.5ml Eppendorf tube, I 
added 2ul Benzonase followed by incubation for 5 minutes at room temperature, to 
cleave long DNA stretches in the sample. 
 
High salt extract 
This protocol enriches for nuclear proteins and most factors can be renatured after 
extraction. Amounts in the protocol are calculated for 1x10
8
 cells. 
Culture plates are each first trypsinized by adding 2ml trypsin and neutralizing that with 
2ml medium after the cells detached. Then, cells are centrifuged at 200g for 1 minute at 
room temperature. In case of HeLa S3 cells, the trypsiniziation is not required and the 
culture is centrifuged directly. After this, the pellet is washed once with PBS and once 
with ice-cold hypotonic buffer (10mM HEPES pH 7.9, 10mM KAc, 1.5mM MgAc2, 
1mM ATP, 1mM DTT, cOmplete – EDTA free, 10μM MG132), then resuspended in 5ml 
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hypotonic buffer (HB). Next, the solution is placed into a 7ml douncer using the tight fit 
piston, and homogenized 10 times. The solution is assayed afterwards under a 
microscope and the percentage of nuclei/all cells is estimated, yielding typically 60-90% 
nuclei. The lysate is then centrifuged 10min 16k g 4°C to separate nuclei from the 
cytosolic fraction. After removing the cytosolic fraction, the nuclei are treated with one 
third volume high salt buffer (1800mM KAc, 10mM HEPES pH 7.9, 1.5mM MgAc2, 
1mM ATP, 1mM DTT, cOmplete-EDTA free), and incubated for 1 hour on ice for 
protein extraction. The extract is then centrifuged 80min 55 000rpm at 4°C in a TLA 
100.3 rotor in thick wall tubes to remove any cell debris from solution. The soluble 
fraction is then dialyzed for minimum 3 hours against dialysis buffer (10mM HEPES pH 
7.9, 100mM KAc, 1.5mM MgAc2, 0.5mM DTT, cOmplete-EDTA free) using the 
Spectra-Por MWCO 6-8000 dialysis membrane. The dialyzed protein extract is then 
supplemented with glycerol to an end concentration of 10%, and finally shock-frozen in 
liquid nitrogen and stored at -80°C. 
 
Co-IP extract 
This extract preparation protocol offers quick cell lysis while maintaining some protein-
protein interactions. In order to achieve this, I prepared the cells similarly to RIPA 
extracts, but instead of RIPA buffer, I used Co-IP lysis buffer (20mM Tris pH8.0, 
150mM NaCl, 10% glycerol, 0.5% NP-40, cOmplete-EDTA free, 10μM MG132). 
3.2.6 Western blot 
I added 5x Laemmli buffer (Laemmli 1970), to a final 1x dilution to each sample prior to 
starting a Western blot. To denature proteins, I incubated the samples for 5 minutes in a 
sand bath at 95°C. After cooling on ice, they were kept at room temperature while the gel 
was being assembled. 
To cast a gel, I first washed with deionized water and ethanol, and then assembled two 
glass plates separated by plastic spacers, and placed them in a film of warm, 0.8% 
agarose solution. I let the agarose solidify to seal the bottom of the glass container. After 
this, the polyacrylamide gel material was prepared. Unless otherwise stated I used 11% 
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polyacrylamide to buffer ratio, which is still rigid enough to be handled by hand, but also 
allows good separation of proteins between 30-50 kilodaltons. For an end volume of 
15ml I added together 5.5ml PAA (Polyacrylamide; 33% stock, Rotiphorese gel 30), 3ml 
5x TG buffer (1.875M Tris-Base, 0.5% SDS, pH 8.8), 6.35ml dH2O, 0.03ml TEMED 
(Tetramethylethylenediamine), and 0.125ml 10% APS (Ammonium Peroxodisulphat). 
After adding together these components, I poured the gels quickly into the cast, and 
layered 1ml isopropanol on top to create an even surface. After the gel solidified, I 
decanted the isopropanol and filled the cast with a concentration gel consisting of 0.66ml 
PAA, 2.5ml SG buffer (0.25M Tris-Base, 0.2% SDS, pH 6.8), 1.8ml dH2O, 0.01ml 
TEMED, 0.05ml APS, and a pinch of Bromophenol blue. The comb was placed into this 
solution and was left to solidify. The collection gel allows sample components to enter 
the gel together and create a sharp running front. This is divided into protein components 
during the electrophoresis and yields sharp, easily identifiable bands. 
Once the gel was ready, it was placed into the running chamber which in turn was filled 
with running buffer (192mM Glycine, 25mM Tris-Base, 0.1% SDS, pH9.0 (textbooks 
suggest pH8.3, but with pH 9.0 the running front is better focused and the gel runs 
faster)). After loading the samples, I performed the electrophoresis at 300V, 35mA, until 
the running front reached the bottom of the gel. After this I disassembled the chamber 
and placed the gel into a transfer sandwich (from top to bottom: 2 pieces of whatman 
paper – gel – membrane (Amersham Hybond ECL from GE healthcare) – 2 pieces of 
whatman paper) and transferred it in a semi-dry transfer unit for 1H at 15V, 400mA using 
running buffer with 20% MeOH. After transfer I washed the membrane in water and 
PBST (PBS with 0.1% Tween-20), and blocked it for 30 minutes in 5% milk solution. I 
applied the primary antibody for minimum 2 hours at room temperature, or 4°C overnight 
with the dilution stated Chapter 3.1.3. Following incubation I washed the membrane three 
times in PBST and applied the secondary antibody in 2.5% milk solution for 1 hour at 
room temperature. Next, I washed the membrane twice in PBST, once in PBS and once in 
H2O and placed it in a transparent plastic bag. For the ECL reagent, I added 10ml of 
solution A (200ml end volume, with 340mg (200mM) p-Coumaric acid (sigma# C9008-
1G) in 500μl DMSO; 2.26g (1.25mM) luminol (Fluka# 09253) in 1ml DMSO; filled with 
Tris pH 8.9) and 60μl solution B (3% H2O2 (Sigma# 21676-3) in dH2O) evenly on the 
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membrane. After 2 minutes of incubation, images were made in a dark room using CEA 
medical x-ray screen film blue sensitive, EC84A films. Quantification of the images was 
done using the ImageJ software’s built in gel quantification option with the recommended 
settings, making sure that the exposure of the films was in the linear range, and that the 
scanning introduced no compression to the images. 
3.2.7 Plasmid-binding assay 
Plasmid-binding assays were used to study protein-DNA interactions in vitro as seen in 
Figure 7. First, I coupled biotin to the plasmids by diluting the stock photoprobe (S-S) 
biotin solution of 1mg/ml 1:10 in dH2O. This I then added to 50 pmol of plasmid to 
achieve a 1:18 plasmid:biotin ratio and filled it to an end volume of 200μl with dH2O. 
Then, I irradiated the solution with a 365nm UV lamp (4W) from a 2cm distance on ice 
for 30 minutes. After that, I added 400μl Tris pH9.5 (1M) and 800μl 2-butanol and mixed 
it with a table-top vortex vigorously. I have done a round of centrifugation for 16000g, 5 
minutes at 4°C in order to separate the butanol phase with the excess biotin from the 
DNA-water phase. After a second 2-butanol wash I performed an ethanol precipitation 
(Sambrook & Russel 2001). I solved the clean, biotin-coupled DNA in 50μl dH2O and 
added it to 100μl streptavidin coated magnetic beads (Dynabeads), which I prewashed 
once with the binding buffer from the Dynabead kit. I added 400μl binding buffer and 
50μl dH2O to the bead-DNA mix and placed the complete solution on a roller overnight 
at room temperature. The next day I washed it three times with 100μl washing buffer and 
stored it in 100μl washing buffer at 4°C. 
Afterwards, I washed 10μl from the immobilized DNA twice in RB buffer (20mM 
HEPES pH 7.9, 5mM KAc, 1.5mM MgAc2, 100μM DTT, 0.003% NP-40, cOmplete-
EDTA free) and added 34μl RB buffer, ATP (40μM), purified proteins (if present) and 
6μl of HeLa commercial nuclear extract (if not stated otherwise) to the beads and placed 
them on a heating block/shaker at 1200rpm for 30 minutes at room temperature. After 
this I washed the beads three times with 100μl RB while incubating the beads for 5 
minutes on the shaker at 1200rpm at 4°C. Finally, I added 20μl laemmli buffer to the 
beads and continued with the Western blotting protocol. 
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3.2.8 Protein expression and purification 
For protein expression in bacteria, the following protocol was used. I transformed 
ROSETTA2 DE3 pLYS S bacteria with pET vectors containing the gene of interest, by 
performing the bacterial transformation protocol detailed in chapter 3.2.12. For the agar 
plates I added chloramphenicol to an end concentration of 25μg/ml. Using a freshly 
picked colony from the transformation, I inoculated 3ml of LB medium with 100μg/ml 
ampicillin, and placed it into an incubator overnight at 37°C. The next day I used 750μl 
from this starter culture to inoculate 250ml of ZYM 5052 medium. 1L ZYM 5052 
medium consists of 958ml ZY (1% tryptone, 0.5% yeast extract, dissolved in dH2O), 
20ml 50xM (1.25M Na2HPO4-7H2O, 1.25M KH2PO4, 2.5M NH4Cl, 0.25M Na2SO4 
dissolved in 700ml dH2O at 42°C), 20ml 50x5052 (25% glycerol, 2.5% sucrose, 10% 
lactose), 2ml 1M MgSO4, 0.2ml 1000x trace elements (50mM FeCl3, 20mM CaCl2, 
10mM MnCl2, 10mM ZnSO4, 2mM CoCl2, 2mM CuCl2, 2mM NiCl2, 2mM Na2MoO4, 
2mM Na2SeO3, 2mM H3BO3 in 60mM HCl) and 50μg/ml ampicillin.  
I incubated the culture for 3 hours at 37°C with 200rpm shaking, and when OD600 
reached 1-2, I placed the culture to 20°C overnight. The next day I collected the cells 
when the culture stopped growing and centrifuged them at 3000rpm, 4°C for 10min in a 
JA10 rotor. Afterwards I resuspended the pellet in 20ml lysis buffer (50mM NaHPO4, 
300mM NaCl, 10mM imidazole, pH 8.0 with NaOH), added 1mg/ml lysozyme and 
incubated for 20 minutes on ice. Then I supplemented the solution with 10μg/ml RNase 
A and 5μg/ml DNase 1 and incubated it again for 10 minutes more on ice. Then I 
fractured the cells via sonication using an ultrasound tip for 10x10s with 40% strength on 
ice, followed by a centrifugation at 10000g for 1 hour at 4°C. Finally, I purified the 
supernatant fraction containing the soluble proteins using the Strep-tactin purification kit 
according to the manufacturer’s instructions. 
3.2.9 Immunoprecipitation 
I performed immunoprecipitations on ice, or at 4°C. First, I prepared low-bind Eppendorf 
tubes and pipetted 5-30μg antibody along with 50μl protein extract and placed this on an 
Material and Methods 
 
 
- 44 - 
over-head rotator for 1 hour. Meanwhile I washed 20μl protein G sepharose twice with 
PBS. After the incubation I added the extract-antibody mix to the beads and allowed it to 
rotate for 1 hour more. Finally, I spun the solution down at 200g for 1min at 4°C and 
added 20μl 2x laemmli buffer to it. 
3.2.10 Pull-down 
Pull-downs were performed using the Strep-Tactin kit from IBA Lifesciences according 
to the manufacturer’s instructions. 
3.2.11 Polymerase chain reaction 
PCR was performed to rapidly amplify DNA stretches for cloning (Mullis et al. 1986). 
For each reaction I used the Pwo DNA polymerase for high fidelity amplification, and the 
primers listen in chapter 3.1.1. Purification of PCR products was done by agarose gel 
electrophoresis as discussed in chapter 3.2.14. 
3.2.12 Bacterial transformation 
Transformation of E. coli bacteria was performed to introduce plasmids into the cells for 
DNA or protein production. Electroporation was only performed for plasmid rescue 
assays, and it is detailed there. Here, the heat-shock method is presented using competent 
E. coli cells generated according to the Inoue protocol (Sambrook & Russel 2001). 
First I added 10ng plasmid DNA to a 15ml Falcon tube while I defrosted the competent 
cells at 37°C and then incubated them on ice for 10 minutes. Next, I added 50μl 
competent cell solution to the plasmids and incubated them on ice for 30 minutes. This 
was followed by the heat shock at 42°C for 90s, after which I put the solution back on ice 
for 12 minutes. Then I added 800μl LB medium to the cells and incubated them at 37°C 
for 45 minutes. Finally, I centrifuged the cells for 5 minutes at 3000rpm, decanted the 
supernatant and transferred the pellet in 200μl LB to an agar plate carrying the required 
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selection marker. After an overnight incubation at 37°C, I picked single cell colonies 
from the plate. 
3.2.13 Plasmid preparation 
Mini- and maxipreps were employed to isolate plasmids from E. coli cultures. For this, I 
used the JETSTAR plasmid preparation kit according to the manufacturer’s instructions. 
3.2.14 Agarose gel electrophoresis 
To isolate DNA fragments from multiple products and to monitor plasmid integrity, I 
performed agarose gel electrophoresis using 0.8% agarose gels (TAE) supplemented with 
1μg/ml ethidium bromide. For visualizing DNA, I used a 365nm UV lamp. For 
preparative work, I took advantage of a 254nm wavelength UV lamp which reduces 
damage to DNA. Products from the extracted gel pieces were cleaned using the 
Nucleospin-Extract II kit according to the manufacturer’s instructions. 
3.2.15 Mass spectrometry 
For mass spectrometry, immunoprecipitation was performed as described in chapter 
3.2.9. To reduce risk of keratin contamination I prepared samples on ice, under a fume 
hood and handled them with sterile gloves and sealed lab coat sleeves. For the 
experiment, I used 200μl of HeLa commercial nuclear extract and 100μg of antibody, the 
latter being covalently coupled to 100μl sepharose G beads as described elsewhere 
(Sambrook & Russel 2001). I loaded the samples into an electrophoresis chamber 
assembled in the fume hood, with gel material and glass sheets similar to those described 
in chapter 3.2.6 but using material specifically prepared for mass spectrometry and 
cleaned with ddH2O. Also, I prepared the gel without a concentration gel on top, only the 
separation solution was used. I stopped the electrophoresis once the blue front reached 
2cm into the separation gel. Then, I used the Colloidal Blue staining kit from Life 
Technologies, according to the manufacturer’s instructions to stain the gel. Next, I cut out 
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the entire lane containing the proteins in five separate pieces, using new, sterile scalpels 
for each cut. I placed each gel piece into a PCR tube containing 200μl ddH2O. The 
samples were then handled by the Mass Spectrometry Core facility of the Biomedical 
Center at the Ludwig-Maximillians-University of Munich, as described elsewhere 
(Schreiner et al. 2012). I then took the identified, Mascot searched spectra, and using the 
Scaffold proteomic software performed statistical analysis using Fisher’s exact test to 
identify any proteins enriched over background (Zhang et al. 2006). Functional clustering 
was done using DAVID and STRING, with the recommended settings.
 
4. Aim of the Study 
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The aim of this study is to better understand the role of the Orc6 protein in the human 
cell. HsOrc6 is the least studied component of the human origin recognition complex, and 
its role is obscure despite numerous studies exploring DNA replication initiation. ORC is 
highly conserved among eukaryotes, therefore studies in model organisms provide much 
needed insight into the function of the complex. However, Orc6 itself is the fastest 
evolving subunit, which results in contradictory observations in model organisms that are 
often difficult to interpret in a human setting. Because of this, validation of these results 
in humans and further elucidation of HsOrc6 function is a much-needed addition to the 
current model of DNA replication initiation. 
 
To better understand the place of HsOrc6 in ORC, first a mechanical study shall be 
conducted elucidating how Orc6 interacts with the pre-replication machinery. Apart from 
the mechanism of Orc6-Orc1-5 attachment and localization, the DNA binding of ORC 
and the role of Orc6 in this process shall be explored in detail. 
 
Secondly, a functional analysis of Orc6 shall be conducted in live cells to elucidate how 
this factor contributes to replication initiation. There is prior evidence that Orc6 is able to 
recruit the replication machinery to designated sites on chromatin, and this function shall 
be mapped down to the domain level of this subunit. 
 
Lastly, I shall follow up mounting evidence that Orc6 is involved in cellular processes 
other than DNA replication. By analyzing interaction partners of HsOrc6, I shall identify 
new pathways the protein is involved in to give a more complete picture of the function 
of Orc6 in the human cell. 
5. Results 
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5.1 Characterization of Orc6 
interaction with the replication 
machinery 
5.1.1 Orc6 is present in abundance compared to other ORC 
subunits 
To characterize how Orc6 interacts with the other ORC subunits, I first needed a better 
understanding of how ORC proteins coexist in the cell. Knowing the amounts of 
individual ORC components present is crucial in understanding complex formation. 
Therefore I first quantified the amount of Orc2 and Orc6 subunits in the cell. It has been 
shown by others that Orc1-6 is more abundant in transformed than normal cells (Di Paola 
& Zannis-Hadjopoulos 2012) and that Orc1-5 levels are higher in proliferating than in 
resting cells (Thome et al. 2000). Orc2, Orc4 and Orc5 levels have even been quantified 
in CHO cells (Wong et al. 2011). However, it was not previously known how Orc6 is 
expressed compared to the other subunits. To examine if Orc6 is expressed to similar 
levels as the other ORC components, I have quantified the level of Orc6 and Orc2 in two 
widely used cell lines: the HEK-293-D kidney cancer cell line, and Raji, an EBV positive 
B cell line. Immunoblot signal intensities of whole cell extracts and highly purified Orc2 
and Orc6 proteins were employed for quantification. 
First, I loaded the purified proteins onto Coomassie gels, and analyzed them for purity. 
Next, I assayed the concentration of these samples using the Bradford method (data not 
shown). Meanwhile, I also prepared RIPA extracts from HEK-293-D and Raji cells, 
ensuring that the cells are completely solubilized during the procedure by repeated 
agitation with a pipette. Subsequently, I loaded dilutions of 250x to 4000x of the purified 
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proteins onto a polyacrylamide gel, with three dilutions from the RIPA extracts next to 
them. The antibody staining after the blotting procedure (detailed in chapter 3.2.6) was 
done with either a purified rabbit antibody for Orc2 or the rat monoclonal antibody 3A4 
for Orc6. I took special care to ensure that while films were exposed to the 
chemiluminescent signals of the blots, the signals stayed in the linear range of the 
sensitivity of the films used. 
 
Figure 5. Amounts of Orc2 and Orc6 in HEK-293-D and Raji cells. Whole cell extracts were prepared 
from either Raji or HEK-293-D cells, and immunoblotting was carried out to visualize Orc6 and Orc2 
signals. Protein levels were quantified by comparing these signal intensities to a dilution series of purified 
proteins. The average of three independent experiments are presented, the error bars show standard 
deviation. 
I scanned the films displaying the signals of the purified proteins and the assayed cell 
extracts in high resolution and without image compression to ensure that the signals 
remain unchanged while digitalized. Finally, I analyzed the image files using ImageJ’s 
gel quantification option. A line was fitted to the values obtained from the purified 
proteins, which created a curve capable of translating immunoblot signal intensities to 
protein concentration. The signals observed in the extract lanes were compared to the 
curves, while making sure that each extract signal was only compared to its unique 
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purified protein dilution curve, excluding inaccuracies from different exposure times and 
possible differences in gel handling. Immunoblotting was performed in triplicates, and 
from each membrane three films were developed, scanned, quantified, and averaged. 
Similar setups have been successfully used to quantify ORC component levels in yeast, 
Xenopus, and hamster cells (Wong et al. 2011). 
Results in Figure 5 display Orc2 and Orc6 amounts and standard deviations in HEK-293-
D cells in blue, and in Raji in orange. The two cell lines show surprisingly similar 
amounts of protein for both ORC components, with HEK-293-D cells containing about 
twice as much Orc2 than Raji cells. Orc6 levels are even more similar in both cell lines, 
and it is also apparent that Orc6 is expressed to considerably higher amounts in the 
assayed cells than Orc2.  
Despite the abundance of Orc6 in the cell, its involvement in ORC formation is poorly 
understood. Therefore, to get a better understanding of this important step in replication 
initiation, I carried out a more detailed characterization of the binding mechanism of 
Orc6 to Orc1-5. 
5.1.2 Orc6 interacts with Orc1-5 and Cdc6 in solution 
From the pioneer experiments done in yeast, it was originally considered that ORC exists 
solely as a six-subunit complex in the cell. More recent work however has found that this 
might be a yeast specific observation despite the highly conserved subunits in all 
eukaryotes. The first experiments using human cells only found Orc1-5, with a separate 
Orc6 protein in solution (Dutta & Dhar 2000). Later it was established that purified 
human ORC lacked its smallest subunit, but the interaction between Orc1-5 and Orc6 was 
observable using human proteins expressed in insect cells (Vashee et al. 2001). The 
Stillman laboratory later confirmed that Orc3 and 5 are able to co-precipitate Orc6 in 
HEK cell nuclear extracts, but they showed no evidence of Orc6 being able to co-
precipitate other ORC subunits, or Cdc6 (Siddiqui & Stillman 2007). Finally the 
DePamphillis laboratory was the first to show that an intact Orc1-6 complex exists in 
human cell extracts if they overexpress at least one of the subunits (Ghosh et al. 2011). 
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To continue with these experiments, I performed an Orc6 immunoprecipitation using 
endogenous proteins only, to show that Orc6 is able to interact with Orc1-5 in a nuclear 
extract with endogenous proteins, and also that the complete origin recognition complex, 
along with Cdc6, is assembled in solution. I performed the immunoprecipitation with 
established Orc6, Orc2 and Cdc6 antibodies (Ritzi et al. 2003), which I used to directly 
precipitate these proteins from HeLa extracts. As a control, a nonspecific IgG rat 
antibody was used, which was expected to provide no signal. 
Results presented in Figure 6 show that Orc6 is not only able to interact with Orc1-5, but 
also with Cdc6. This finding is confirmed by the presented Orc2 and Cdc6 co-
immunoprecipitations, which depict similar results. Taken together, these data show that 
the ORC-Cdc6 complex forms in solution and can be immunoprecipitated stably from 
human nuclear extracts. Orc3 and Orc5 are not shown in this figure since Orc2-5 has 
been already presented to assemble in solution and to form a stable complex. Therefore I 
propose that these factors are also present. The high background observable in the Orc1 
input and IgG lanes are due to the fact the Orc1 is unstable in HeLa nuclear extracts, and 
is present in sub-stoichiometric amounts (Baltin et al. 2006). Because of this, detection of 
the protein requires long exposure times, which lead to an increased background. 
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Figure 6. Co-immunoprecipitation of pre-RC subunits from nuclear extracts. The ORC-Cdc6 complex 
was precipitated from HeLa nuclear extracts using anti-Orc2, Orc6 and Cdc6 antibodies respectively, as 
indicated on the top. Immunoprecipitation with unspecific rat IgG antibody served as control. For 
immunoblotting, 5% of the nuclear extract used for the depletion was loaded as input. The blots were 
stained with the antibodies indicated on the left. 
It is also notable that the various factors present in the immunoprecipitation are depleted 
to different levels from the extract by the precipitation (data not shown). Orc1 is highly 
enriched in the precipitation even compared to the residual amounts in the input lane, 
whereas Orc6 is still abundant in the extract if it is co-depleted with another ORC 
subunit. This argues for a dynamic or biochemically weak interaction between Orc6 and 
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the core complex, or that ORC components are present in different levels in the cells, 
which also underlines the difficulty of visualizing this interaction.  
Although Orc6 is shown to interact with Orc1-5 and Cdc6 in this experiment, this does 
not contradict previous studies showing the absence of such binding. The higher 
sensitivity of the Orc6 antibody allows detection of minimal amounts of Orc6, which 
support the visualization of this protein in Orc2 and Cdc6 precipitations, but this amount 
might be below the detection limit of antibodies used in previous studies. Also, this 
antibody precipitates the smallest subunit with high efficiency, leading to a higher 
number of co-precipitated proteins, and a more robust signal for Orc6 interactors. 
Now that the assembly of these factors in solution is better understood by showing that 
the full ORC-Cdc6 complex is already preassembled in solution, the next step is to 
analyze the DNA binding characteristics of the complex. To better understand the place 
of Orc6 in ORC-DNA binding, an in-vitro system is required which allows the study of 
this process. 
5.1.3 200bp but not 36bp of DNA is sufficient for ORC to attach 
The interaction of ORC with DNA, and the role of Orc6 in it, is a focal point of 
replication initiation. Better understanding this step is one of the main goals of this work. 
In order to study it, I employed a cell-free pre-RC assembly assay. This method, termed 
the plasmid-binding assay, utilizes replication competent nuclear extracts, and their 
ability to assemble the pre-RC onto DNA in a sequence independent manner. It was 
originally developed to study the effect of viral factors in replication initiation 
(Schaarschmidt et al. 2004; Thomae et al. 2011), but has emerged as an excellent tool to 
elucidate the mechanism of pre-RC formation in great detail. 
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Figure 7. Schematics of the plasmid-binding assay. This 
assay allows the study of pre-RC formation on DNA in a cell 
free system (Thomae et al. 2011). Plasmid DNA is first coupled 
to biotin, and then to magnetic beads. The immobilized 
plasmids are then incubated with replication competent nuclear 
extract to allow complex formation on DNA. After incubation 
the beads are separated from the solution with a magnet, and 
washed to remove unspecific binders. Finally, DNA bound 
proteins are eluted and analyzed in downstream applications. 
The assay requires a DNA template, usually a 
plasmid, which serves as the assembly site of pre-
RCs. It has been established that supercoiled 
plasmids are better suited for in vitro replication 
assays, as the replication machinery binds with 
higher affinity to such plasmids (Baltin et al. 2006; 
Zembutsu 2006). To make use of this, I first 
subjected the purified plasmids to Cesium Chloride 
gradient centrifugation (Sambrook & Russel 2001), 
which enriches for supercoiled structures.  
I used a small dose of UV light to incorporate 
reactive biotin into the prepared plasmids, which I 
subsequently coupled to streptavidin coated 
magnetic beads. Then I mixed the immobilized plasmids with a protein extract, which 
contained all components for pre-RC formation. It has been elucidated that nuclei 
prepared from HeLa cells which are then treated with 450mM KAc, release pre-RC 
components from chromatin creating a replication competent nuclear protein extract 
(Baltin et al. 2006). Once this extract has incubated with the immobilized plasmids, I 
separated the beads from the solution via a magnet. Then I washed the beads to remove 
unspecific binders, and the specific proteins were finally eluted with detergents and 
boiling as detailed in chapter 3.2.7. Finally I subjected the eluate to Western blot analysis 
to identify bound proteins. 
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Pre-RC components successfully bind DNA in the assay as shown in Figure 8. Here, I 
performed the plasmid-binding assay by using either magnetic beads without DNA, an 
immobilized linear construct, or a circular, supercoiled plasmid respectively. By using 
different templates, I was able to examine if the involved factors have a preference for a 
specific DNA structure. Other studies have shown that in vitro replication assays perform 
better on supercoiled plasmids. Also, it has been postulated that MCM complexes loaded 
during pre-RC formation may slide freely on a naked stretch of DNA, and might 
therefore get lost from a linear construct (Baltin et al. 2006). The results show that both 
the linear and the circular DNA template recruits the complete pre-RC, as seen by the 
presence of ORC and MCM complexes. The former is visualized via Orc4, 5 and 6, 
showing that not only Orc2-5, but also Orc6 is DNA bound in this experiment. By 
visualizing Mcm3 and Mcm5 I present evidence that the entire MCM complex is present 
as this is known to form a ring-like structure with all six subunits in solution, and bind as 
a whole to ORC. As discussed in the introduction, MCM complexes are bound to origins 
in two distinct steps. First, they are recruited and attached to ORC, and second, they load 
onto DNA encircling the double helix. The two can be distinguished by the high salt 
resistance of the proteins, as loaded MCMs are resistant to high salt treatment and stay 
DNA bound, whereas if only recruited, their signal is lost (Remus et al. 2009). My 
experiments established that the Mcm3 and Mcm5 signals presented in Figure 8 are not 
resistant to high salt, and therefore are not loaded onto chromatin but are only associated 
(data not shown). However, this does not hinder the assembly of ORC as this happens 
before MCM recruitment and shows to be complete and efficient in this in vitro system, 
and is able form the basis of subsequent experiments. 
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Figure 8. Recruitment of pre-RC components onto plasmid DNA in vitro. Plasmid-binding assay was 
performed by using replication competent nuclear extracts to assemble the pre-RC in vitro. Plasmid-bound 
proteins were subjected to Polyacrylamide gel electrophoresis, and visualized by immunoblotting using 
antibodies against the proteins indicated on the left. The first 3 lanes are supernatants collected from the 
assay showing 10% of the unbound proteins left after the experiment. The following three lanes show 
proteins bound to either magnetic beads only (B), a linear DNA fragment (vertical line) or a circular 
plasmid (circle). 
After establishing that the plasmid-binding assay is working as intended and can be used 
to study ORC-DNA binding in more detail; in vitro DNA requirements of ORC 
formation were studied. First, I analyzed the minimal length of template DNA which can 
recruit ORC components. I excluded other pre-RC factors, such as MCMs, from further 
analyses as their recruitment was inefficient compared to that of ORC. Furthermore, ORC 
assembly and DNA binding happens before MCM loading, therefore the downstream 
mechanisms of MCM recruitment are not part of ORC assembly dynamics. 
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Figure 9. Effect of competitor DNA fragments on ORC-DNA binding. Plasmid-binding assays were 
performed with additional free DNA added to the solution before the addition of the nuclear extract. Bead-
bound proteins were afterwards analyzed in Western blots by using antibodies specific for the proteins 
indicated on the left. The first panel shows 5% protein extract input as control. Each panel displays a 
control with only magnetic beads without coupled DNA (B), followed by a control assay with no 
competitor DNA. After this, assays loaded with increasing amounts of free competitor DNA in equimolar 
amounts are shown. The presence of competitor DNA is indicated on the top. 
Figure 9 shows DNA length requirements of ORC formation. For this experiment I made 
a plasmid-binding assay (introduced in Figure 7 and tested for functionality in Figure 8) 
to determine if a 36bp, a 200bp, or a 3000bp long linear DNA strand is long enough to 
recruit ORC. I used a regular assay with immobilized pUC19 plasmids and HeLa nuclear 
extracts. However, before mixing the bead-bound plasmids with the extract, I added free 
competitor DNA to the solution as indicated in Figure 9. This way, once the extract was 
added, the proteins in it could either bind to the bead-bound constructs or to the free 
competitor DNA. Only the bead-bound plasmids were subjected to purification and their 
contents analyzed by Western blotting, which means if the non bound competitor DNA 
was able to effectively recruit ORC components, then these factors would be present on 
the immobilized constructs in smaller amounts, leading to a decrease in signal intensity. 
This is observed in the rightmost panel in Figure 9 where linearized pUC19 was used as 
competitor DNA in increasing amounts. The beads only control (B) displays a small 
signal for Orc1 and 4, and a prominent band for Orc6. The latter is of significant interest, 
as Orc6 has some affinity to streptavidin-coupled beads, providing background in these 
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experiments. However, upon DNA binding, Orc6 forms a double band on gels in an ATP, 
extract and time dependent manner (data not shown), which allows easy distinction of 
specific and unspecific signals. Since only the lower running form binds beads 
effectively, the upper band stands as evidence of DNA bound Orc6. With this in mind, 
the signals in the rightmost panel show how free competitor pUC19 DNA depletes all 
ORC subunits from immobilized plasmids. This however is only a control, as it was 
already established in Figure 8 that pre-RCs are able to assemble on plasmids of 3kb. 
New information is provided by the right panel, which displays the effect of a 200bp long 
competitor DNA piece. This has a similar effect as the pUC19 competitor, leading to the 
conclusion that a 200bp DNA fragment is sufficient to serve as a binding site for ORC. It 
is worth noting that all ORC subunits are depleted in a similar manner, despite having 
different amounts in the cell, as shown in Figure 5. This indicates that ORC assembles on 
DNA with a given stoichiometry. The result is different for the shortest oligonucleotide 
of 36bp displayed in the left panel of Figure 9. Here the signals are at the same level in all 
lanes, despite the fact that there are increasing amounts of oligonucleotides present. From 
this it can be concluded that a 36bp long DNA fragment is not sufficient to serve as an 
ORC binding template.  
Since similar molar amounts of DNA strands were used in all three panels, it could be 
argued that the 36bp construct shows no effect because there are fewer nucleotides in the 
assay. This is because using an identical number of molecules in both the 200bp and the 
36bp blots would lead to the presence of a lower mass (ng) of nucleotides present in the 
assay with the shorter template. To overcome this problem and to show that the observed 
depletion effect is due to the presence of DNA strands that recruit ORC and not simply 
because of the presence of nucleotides, and extra lane was added to the 36bp panel, 
where an even higher amount of DNA was used to provide the same mass of nucleic 
acids in the assay as in the rightmost lane of the 200bp DNA fragment. However, even 
this lane shows no depletion effect, therefore I concluded that not the amount of 
nucleotides present is actually important, but the number of possible binding sites of a 
critical length which are able to serve as a template for ORC. This contradicts a previous 
study in Xenopus, where it was shown that the presence of short DNA pieces increases 
ORC binding signals (Lebofsky et al. 2010). This however can be due to differences in 
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embryonic extracts used for the Xenopus study, which are shown to have an unusually 
high replication competence only observed in embryonic systems. Also, the Xenopus 
study directly measures replication of template DNAs in the presence of small DNA 
fragments, not the buildup of ORC or pre-RCs, which are not affected in this experiment. 
The size of oligonucleotides capable of recruiting ORC fall between 36 and 200 base 
pairs, which is in line with other studies: in yeast, a study predicted a 72bp DNA binding 
site for ORC-Cdc6 (Sun et al. 2012), and the 80bp DNase I footprint was observed (Bell 
& Stillman 1992; Speck et al. 2005). In metazoans, a Xenopus study using the same 
method as I did found that an 82bp, but not a 67bp fragment was sufficient to recruit 
ORC (Edwards et al. 2002). 
Since the composition of DNA and the presence of particular sequence motifs has been 
shown to have little effect on ORC formation (Schepers & Papior 2010), and the binding 
site range has been here elucidated, next I studied the protein requirements of ORC 
binding, to obtain information on the relative binding affinities of the subunits. 
5.1.4 Orc6 saturates similarly to Orc2-5 when binding to DNA 
The molar amounts of Orc6 and Orc2 are different in nuclear extracts as shown in Figure 
5. However, their presence in the extract and ultimately in the cell do not mean that they 
are equally able to be recruited to DNA, despite having shown that the ORC-Cdc6 
complex forms in solution. To establish if only the complete origin recognition complex 
binds to DNA, or individual subunits can do so on their own, a saturation assay was 
performed. Increasing amounts of protein extract was added to a constant amount of 
DNA template. This experiment is expected to provide data on the relative binding 
affinity of individual ORC subunits. 
Figure 10 shows Orc1, 2, 4 and 6, and Cdc6 binding and saturation on either pUC19 or 
the pEPI-UPR plasmids as template. In addition to the standard pUC19 plasmid for the 
plasmid-binding assays, I supplemented the experiment by using the pEPI-UPR construct 
for comparison, as it has been established that this is able to serve as template for in vitro 
replication experiments (Schaarschmidt et al. 2004). Here, the widely used pEPI plasmid 
backbone contains the UPR insert, which is the upstream promoter region of the human 
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MCM4 gene, an established ORC binding site (Ladenburger et al. 2002). In Figure 10 I 
used equal molar amounts of the two plasmids for both biotinylation and bead coupling, 
and then added equal microliters of bead solution for the plasmid-binding assays. This 
ensured that the same molar amount of plasmids were present in all lanes, although since 
the pEPI-UPR plasmid is about 3 times longer than the pUC19 plasmid thus pEPI could 
have possibly provided more room to bind pre-RC factors per plasmid. 
The amount of extract is increased from left to right, starting with zero, and gradually 
increasing as indicated at the bottom of Figure 10A. After 6µl, a beads only control and a 
pEPI plasmid using assay is also shown as comparison. These show similar background 
signals in the beads only (B) lane as in Figure 9, and surprisingly weaker signals for the 
pEPI plasmid as for the pUC. After these three lanes, the same experiment is shown, but 
with double (12µl) or triple (18µl) amounts of nuclear extract. A quantification of 
observed signals is presented in Figure 10B. 
Results show that Western blot signals gradually increase as more extract is added for all 
proteins analyzed, but that Orc1 and Cdc6 show different saturation points in comparison 
to Orc2-Orc6. This is obvious in Figure 10B where the quantified signals are displayed in 
a diagram. Orc2 and Orc4, members of the core ORC, reach saturation at around 4µl. 
Also, Orc6 reaches the plateau at this amount, which is interesting as Orc6 amounts are 
significantly higher than core ORC component abundance in the cell. Although the 
extracts used are not whole cell extracts as in Figure 5 but HeLa nuclear extracts, it is still 
likely that Orc6 is more abundant in the nuclear extract than other ORC subunits. This 
leads to the conclusion that Orc6 behaves similarly to Orc2-5 when binding to DNA. 
The Orc1 signal intensity on the other hand is increasing until the maximal 18µl, which is 
similar to the results of previous studies where adding extra, recombinant Orc1 to in vitro 
replication assays increased replication competence (Baltin et al. 2006).  
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Figure 10. Binding saturation of ORC components on plasmid-DNA in vitro. Plasmid-binding assays 
were performed with constant amounts of template DNA and increasing amounts of nuclear extract to 
determine saturation of ORC components on DNA. Resulting Western blots with antibodies against 
selected pre-RC proteins are shown in A). Aside from the 3kb pUC19, the 10kb pEPI-UPR plasmid 
template was also tested in equimolar amounts as indicated on the top, with beads only serving (B) as 
control. Increasing amounts of nuclear extract is indicated at the bottom. B) presents the quantification of 
pUC19 signals from the blot in A), with the 18µl signal taken as 100% for each dataset. From Orc6 the 
upper, DNA specific band was quantified. The x-axis shows the amount of nuclear extract used for each 
data point. 
Furthermore, the saturation point of Cdc6 is reached only with 12µl nuclear extract. This 
point falls between that of Orc1 and other ORC components leading to the conclusion 
that Orc1 is present in the most limiting amount among these factors during in vitro 
replication initiation, possibly due to either partial degradation during extract preparation, 
or low expression in HeLa cells. 
The experiment also proved that the ORC-Cdc6 complex, despite forming in solution, 
can possibly assemble on DNA as well, or at least different sub-complexes of ORC-Cdc6 
might differ in their DNA-binding characteristics. To further elucidate whether ORC 
components can bind separately to DNA, and to receive more information on how Orc6 
interacts with other ORC subunits upon binding DNA, I performed plasmid-binding 
assays depleting specific ORC components. 
5.1.5 Orc6 is able to bind DNA independently of ORC 
One of the aims of this study is to better understand the mechanism of ORC-DNA 
binding, with respect to the function of Orc6. Looking at this mechanism in detail, this 
chapter explores if ORC subunits require each other to bind to DNA. To achieve this, 
individual subunits were depleted form the nuclear extract prior to addition to DNA In 
the plasmid-binding assay. 
From yeast studies it was established that Orc1-5 binds DNA without the need for Orc6 
to be present (Lee & Bell 1997). However in Drosophila, Orc6 is crucial for ORC-DNA 
interaction (Chesnokov et al. 2001). Based on this knowledge, one main question in the 
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case of human cells is: is Orc6 required to recruit ORC to DNA? To answer this, I 
prepared two different depletions. First, Orc6 depletion would have to show if Orc6 is 
required for Orc1-5 recruitment in this assay, and second, the depletion of the core ORC 
(Orc2-5) should elucidate if Orc6 can bind to DNA on its own. The results of this 
experiment are shown in Figure 11. After an extract only control (INP), and a beads plus 
extract control (B), I prepared a full plasmid-binding assay that also includes DNA 
templates, either in the presence or absence of ATP. Following this is a depletion control 
using an unspecific antibody, and finally, Orc2 and Orc6 depletions in the two rightmost 
lanes. The image shows that Orc2, which represents the core ORC, can bind in the 
absence of Orc6, and also Orc6 is able to attach to DNA if the core complex is not 
present. Surprisingly, this feature is more similar to the results from yeast, than the ones 
from the more closely related insect species. Adding the fact that HsOrc6 is structurally 
more similar to DmOrc6 than ScOrc6 (Duncker et al. 2009), the result is even more 
unexpected. 
Additional peculiarities can be observed in Figure 11. First, adding ATP has a distinct 
effect on Orc6 DNA binding, which shows a prominent, higher migrating band if the 
nucleotide is present, which is also observable in Figure 8, Figure 9 and Figure 10. 
Although posttranslational modifications of HsOrc6 are established (Dutta & Dhar 2000), 
and it is a known CDK target (Ghosh et al. 2011), it is still not elucidated what this 
modification might be. It is however dependent on the presence of ATP, and DNA 
binding. 
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Figure 11. In vitro assembly of partially depleted ORC on DNA, and effects of ATP (part I). Plasmid-
binding assay was performed to determine the effects of Orc2 and Orc6 depletion on ORC-Cdc6-DNA 
interaction. 5% extract (INP) and an assay using no DNA template (B) were loaded as control. Plasmid 
bound proteins in the presence or absence of ATP (indicated on the top) are shown in lanes 3 and 4. Effects 
of depleting proteins with an unspecific (IgG), an Orc2 or an Orc6 antibodies are shown in the last three 
lanes respectively. 
Furthermore the IgG depletion makes all observed signals slightly weaker. It has been 
established that a high concentration of proteins is required for an efficient ORC 
formation (Thomae et al. 2011). Adding antibodies to the extract lowers the overall 
protein concentration, leading to a less efficient binding. However, depleting Orc2 
moderately reduces Orc6 signal intensity even if compared to the IgG control. This shows 
that Orc6 binds both independently and in complex with ORC, but the signal difference is 
not prominent enough in a single experiment to be able to reliably tell the difference. 
It is also unexpected that Cdc6 signals are unaffected by any ORC component depletion. 
This shows that either Cdc6 binds to Orc6 and Orc1-5 separately, or more likely it has an 
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innate ability to bind DNA, and since fully assembled ORC-Cdc6 complexes are small in 
number compared to free Cdc6 in extracts (see in Figure 6), the possible loss of signal 
due to the depletion of the full complex is negligible. Having learnt this, I concluded that 
Cdc6 recruitment is not an appropriate control for ORC formation, therefore the 
experiment was repeated using Orc4 antibodies, which stains a prominent component of 
core ORC. 
5.1.6 ORC enhances Orc6 DNA binding 
To clarify the possible Orc6 signal loss observed in Figure 11 and to see the effect of 
ORC component depletion on complex formation, I repeated the same experiment as in 
Figure 11, this time however, I included an Orc4 stain. Despite the small difference in the 
experimental setup, the test yielded valuable information on ORC-DNA interaction. 
In Figure 12 on the left, the three supernatant lanes show the unbound proteins still 
available in the extract after performing the plasmid-binding assay. This shows that only 
a fraction of pre-RC proteins are binding to plasmid DNA from the existing pool. 
Comparing this result to Figure 10 it can also be concluded that upon saturation on DNA, 
pre-RC proteins are present in large abundance in solution.  
Looking at the Orc2 and Orc6 depleted lanes, both proteins are efficiently removed from 
the extract, but they do not co-deplete each other. This is expected from the ORC subunit 
interaction results discussed in chapter 5.1.2. It is also in accordance with the current 
model that Orc2 efficiently co-depletes Orc4. Interestingly, the remaining Orc4 still 
present after Orc2 depletion does not bind to plasmid DNA but remains in the 
supernatant. This means that Orc4, probably with the rest of the core ORC, can only be 
recruited to DNA as a whole. This also indicates that despite the fact that Orc4 and other 
core subunits all have a winged helix domain, a hallmark of DNA binding proteins, they 
still require complex formation to efficiently bind to DNA (Stefanovic et al. 2003). 
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Figure 12. In vitro assembly of partially depleted ORC on DNA (part II). Plasmid-binding assay was 
performed to assess the effects of Orc2 and Orc6 depletion on ORC-DNA binding. Prior to adding the 
nuclear extract to the plasmids, they were depleted with either an unspecific antibody (IgG), an Orc2, or an 
Orc6 antibody as indicated on the bottom. 20% of unbound proteins after the assay (supernatant) and all 
plasmid bound proteins (DNA bound) were stained in Western blots with the antibodies indicated on the 
left.  
It is also very important to distinguish between the role of Orc2 and Orc6 in this 
experiment. Whereas Orc2 is required for Orc4 DNA-binding, Orc6 is not. Therefore it 
can be concluded that unlike in Drosophila, Orc6 is not essential for the Orc1-5-DNA 
interaction. Orc2 on the other hand is crucial for the same process, and its presence might 
stabilize Orc6 DNA-binding as evidenced in lane of Orc2 depletion, where the Orc6 
signal is reduced compared to the IgG depleted control. 
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5.1.7 Orc6 is not required for ORC DNA binding, but it enhances 
the process if present 
Although depletion of Orc6 had no effect on ORC-DNA binding, adding excess Orc6 
might do. Therefore, after depleting endogenous Orc6 from the sample, I added 
bacterially expressed, purified, recombinant HsOrc6 to the plasmid-binding assay. The 
result is presented in Figure 13. 
 
 
Figure 13. Effect of excess recombinant Orc6 on ORC-DNA binding. Plasmid-binding assay was 
performed while adding excess recombinant Orc6 to the reaction. The lane marked with “B” of the 
resulting immunoblot displays a control where no DNA was used, only magnetic beads. This is followed by 
a plasmid-binding assay with DNA as positive control. Orc6 was depleted from the last two lanes using a 
specific antibody. The rightmost lane contains 100ng bacterially expressed HsOrc6 which was added to the 
reaction before mixing it with DNA. Antibodies used for immunoblotting are indicated on the left. 
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After a beads only control (B) Orc6 is observed binding to plasmids as a weak doublet, 
similarly to previous results. Depletion of Orc6 shows no effect on the other factors, 
which is also seen in Figure 11 and Figure 12, but the last lane containing an excess of 
Orc6 induces a significant increase in Orc2 and Orc4 DNA binding. This cannot be an 
effect of adding extra protein, as the 100ng, concentrated, purified protein is minuscule 
compared to the 30μg of nuclear extract present in the assay. Also, in preliminary 
experiments, I used BSA to block the beads prior to adding the nuclear extract to reduce 
background binding. Although this method did not reliably reduce Orc6-background 
signals, and so was subsequently abandoned, it also led to the conclusion that adding 
extra protein has no effect on ORC-DNA binding (data not shown). Because of this I 
concluded that specifically the addition of Orc6 leads to the increased binding of ORC 
components. 
Although the effect is present, the mechanism behind Orc6 enhancement of ORC-DNA 
binding is not yet fully understood. It is speculated that at least in yeast, Orc6 assists in 
the stabilization of ORC by binding Orc2 and a specific segment of Orc1 (Sun et al. 
2012). What domains within Orc6 are active in this process, and how this occurs in vivo 
is yet to be explored. 
5.1.8 Orc6 binds via its C terminus to ORC in vitro 
Having elucidated that Orc6 interacts with ORC and Cdc6 in solution (Figure 6), and that 
the protein is not required for Orc1-5-DNA binding (Figure 11) but enhances the process 
if present (Figure 13), it is still unclear which domains of Orc6 contribute to replication 
initiation. Previous studies trying to dissect or crystallize Orc6 found no known domains, 
contrary to other ORC subunits (see chapter 2.2). Although Orc6 seems to have an 
evolutionary conserved body in most species, even that has only a modest similarity 
between distant eukaryotes. 
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Figure 14. Bacterial expression of recombinant Orc6 variants. The depicted proteins from 1-7 were 
expressed and purified from bacteria. All variants have a Strep-Strep-Flag tag on the N terminus for 
purification and detection purposes. Deletions in the variants are indicated by orange marks. The red bars in 
the S72A K76A and the T195E variant represent point mutations which are indicated in their corresponding 
labels. The full length construct is the tagged, wild-type Orc6, which was used as control. 
To characterize Orc1-5 interacting domains of Orc6, I generated a set of variants as 
displayed in Figure 14. I N-terminally tagged the 252 aminoacid long, full length, wild-
type Orc6 protein with a strep-strep-flag tag for purification and detection purposes. Then 
I truncated the full-length protein by 50 amino acids from either the C terminus, or the N 
terminus, leading to two new variants with unique truncations. The third variant contains 
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both of these truncations, so it is missing both its first and last 50 amino acids, leading to 
a missing N and C terminus. The next one corresponds to a Drosophila homologue in 
which it was shown that two highly conserved amino acids, S72 and K76, are crucial for 
DNA binding of DmOrc6. By mutating both the serine at position 72 and the lysine at 
position 76 to alanines, the DNA binding ability was lost (Balasov et al. 2007). Both 
amino acids are conserved in the human homologue, so I created this variant to provide a 
potentially DNA binding defective protein carrying the S72A, K76A point mutations. An 
additional variant contains a single point mutation compared to the wild-type protein: the 
threonine at position 195 is changed into a glutamate. The purpose of this is to mask a 
predicted CDK phosphorylation site on the protein, and mimic the phosphorylated state. 
Finally, the last derivative is lacking the predicted nuclear localization signal of Orc6, 
which also contains the predicted CDK target site. Therefore this mutant, unlike the wild-
type protein, is expected to remain mainly cytosolic in vivo, and to show a constant, 
unphosphorylated phenotype, as seen in a previous study (Ghosh et al. 2011). 
 
Figure 15. Polyacrylamide gel with purified, bacterially expressed Orc6 variants. Orc6 variants 
depicted in Figure 14 were expressed and purified from bacteria, and loaded onto a polyacrylamide gel 
respectively. After electrophoresis, the gel was stained with the Colloidal Blue staining kit. The number of 
each variant is shown on the top, and correspond to the numbering presented in Figure 14. 
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I first cloned all seven versions into pET21 bacterial expression vectors, and then 
expressed them in BL21 Rosetta cells. Following purification from the bacteria culture 
using their Strep tags, I analyzed the purified proteins via Polyacrylamide gel 
electrophoresis to assess correct product size and purity. 
The purified proteins were then used in pull-downs, and tested for interaction with other 
ORC subunits. To do this, I coupled each purified protein onto a column and 
subsequently added Orc6 depleted nuclear protein extract to it. This allowed binding of 
factors in the extract to the immobilized Orc6, which after washing were eluted and 
finally subjected to Western blotting. 
Figure 16. Interaction of different Orc6 protein variants with Orc1-5 in vitro. Pull-down experiments 
were performed by coupling Orc6 derivatives to columns and adding Orc6 depleted nuclear extracts to 
them. A) Eluates from the 8 separate pull-down experiments were fractionated and fraction 2 loaded onto a 
Western blot gel, which was stained with an Orc2 specific antibody. The Orc6 derivative used for each 
pull-down is indicated on the bottom. The leftmost lane contains 10μl of nuclear extract as input control. 
The last lane is a negative control, where no Orc6 was added. Apart from to the Orc2 signals labeled on the 
left, the Orc6 variants are also visible due to the high amount of eluted protein present on the membrane, 
and the minor cross reactivity of the anti-Orc2 antibody. B) Ponceau-red stain showing proteins on the 
membrane. The Orc6 variants are visible even in the absence of an antibody, due to their high amounts in 
the eluates. A protein size marker is included on the right. 
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Results presented in Figure 16 show which Orc6 variants were able to pull down Orc2, as 
representative for Orc1-5. The last lane features only buffer, no added Orc6 protein, and 
is therefore lacking an Orc6 signal, but also a signal corresponding to Orc2, showing that 
Orc2 has no significant background binding. The input lane shows the correct position of 
Orc2, serving as a positive control. Using these two endpoints as reference, I concluded 
that Orc2 is able to bind all Orc6 variants which have an intact C terminus. Orc6ΔC and 
Orc6ΔNΔC however, which lack this domain show reduced Orc2 binding activity, which 
can only be observed with extended exposure times (data not shown). The weak signal 
next to the input is more likely to be a spillover than an actual signal, confirmed by the 
consistent results with the double truncated construct and replications of this experiment. 
Orc6 S72A K76A contains a surprisingly stronger Orc2 signal, but this is most likely due 
to the higher amount of recombinant protein present in the sample. Although the effort 
was made to use identical amounts of protein in each lane, the different eluates used 
contain varying amounts of Orc6. I also have to note that the blot was not stained for 
Orc6, as the epitope is located in the C terminus of Orc6, and would therefore not give a 
signal with the variants lacking this domain. Instead, the signals seen are from cross-
reaction of the Orc2 antibody with the excess amounts of Orc6 in the sample. The amount 
of recombinant Orc6 was so high in the elution fraction in this experiment that it quickly 
bleached the signal when using an Orc6 specific antibody, and gave a very prominent 
band even with a Ponceau-red stain (Figure 16B). This is however in line with the results 
from Figure 6, which conclude that the biochemical interaction between Orc6 and Orc1-5 
is weak. The result does not in itself mean that Orc6 directly interacts with Orc2. Since an 
extract was used, it cannot be excluded that the interaction detected is independent, and 
occurs via other ORC components or auxiliary factors. Taken together, this experiment 
demonstrates how Orc6 interacts via its C terminus with core ORC in vitro. To confirm 
these results in vivo, other methods were employed. 
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5.1.9 Orc6 needs a nuclear localization signal or its C terminus to 
enter the nucleus 
In vitro experiments allow more direct control over the experimental setup, as they allow 
the study of various systems of an organism independently. This however leads to results, 
which do not hold true in a live organism, as the complexity of an entire cell is much 
greater than that of the individual parts. Therefore, in vitro studies and their results need 
to be validated in vivo. While studying the in vitro association of Orc6 to Orc1-5 I came 
to the conclusion that the smallest subunit requires its C terminal 50 amino acids to 
interact with Orc1-5. To validate this result in vivo, I carried out immunofluorescence 
experiments, which visualize the localization of the proteins of interest inside a complete 
cell. 
For this experiment, new, eukaryotic Orc6 expression vectors were required, as contrary 
to the previous experiments where expression was in bacteria, here the goal was to 
express and study the different Orc6 proteins in human cells. Therefore, I transferred the 
7 already established gene variants introduced in Figure 14 into the bimolecular 
fluorescence complementation vector backbone (pBiFC), which allows eukaryotic 
expression of these proteins. Each construct received an N terminal HA tag for detection 
purposes, and a C terminal YFP tag, which codes either for an N-terminal or C-terminal 
part of the fluorescent YPF protein. The separation of YFP into two domains can be used 
to conduct BiFC assays, which allow the detection of close interactions between two 
proteins (Kodama & Hu 2012). Although wild-type Orc6 has been shown to be able to 
provide a BiFC signal with Orc4, Orc5 and Cdc6 (Thomae et al. 2011) no such signal 
was observed with Orc2 (data not shown). In this experimental setup however, I 
attempted immunofluorescence experiments, which identify the constructs via the use of 
specific antibodies. 
Apart from the seven previously generated versions of Orc6, I established three new ones 
to gain a better understanding of the role of the central area of the Orc6 protein. The first 
of the new variants contains a deletion from amino acids 50-125. This 75 amino acid 
deletion starts just after the 1-50 deletion tested in ΔN variant. The next construct follows 
this by having a deletion from 125-203. As the ΔN variant already has a deletion from 
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203-252, the Δ125-203 construct completes the set of deletion mutants by omitting the 
only fragment of the protein, which all other variants have. The last mutant is a control 
for Δ50-125 and Δ125-203, as it is lacking the entire area from 50-203. This mutant 
basically consists of a C and N terminus only, with all other areas removed in between. A 
cartoon depicting these variants is shown in Figure 16. 
I carried out the immunofluorescence experiment by using HepG2 cells, which is an 
established cell line showing primary cell-like morphology, and is often used for 
microscopy experiments (Knowles et al. 1980). I transfected HepG2 cells with a pBiFC 
plasmid carrying Flag:Orc2:YFP155-253, and each of the 10 different HA:Orc6:YFP1-
155 variants in separate wells. After 18-24 hours of expression, I cross-linked the cells 
with formaldehyde, and stained them with anti-Flag and anti-HA antibodies coupled to 
Cy3 and Cy5 dyes to visualize the location of the expressed Orc2 and Orc6 proteins. 
Although the dyes are excited by different lasers and their fluorescence also occurs at 
distinct wavelengths (Mujumdar et al. 1993), I confirmed independence of the signals by 
identifying clear green and red signals in the cell lines studied. This ensures that the co-
localization observed is not an effect of detecting the same dye in both channels. 
Results shown in Figure 17 present cartoons of each construct used and representative 
microscopy images obtained. A DAPI stain is shown for each image to visualize the 
chromatin. After the antibody signals, the final column shows a merge of the previous 
three images, displaying DAPI in blue, Orc6 in red, and Orc2 in green. Co-localizing 
signals in the merge image appear yellow. 
Figure 17. Cellular localization and Orc2 interaction of different Orc6 variants in vivo. Each of the 
presented HepG2 cells were transfected with FLAG:Orc2 carrying expression plasmids, and plasmids 
encoding the Orc6 variant depicted on the left of each row. After allowing the expression of the fusion 
proteins, the cells were prepared for fluorescence microscopy by fixing them onto microscopy cover slips. 
Subsequently they were treated with anti-FLAG and anti-HA antibodies, and finally DAPI to visualize 
chromatin. Resulting images are displayed showing the color channel of the signal indicated at the bottom. 
The last image in each lane contains a merge of the previous three, depicting DAPI in blue, Orc6 in red, 
and Orc2 in green. These images have been digitally enhanced for printing. For the raw images, see Figure 
26. 
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The results show that all Orc6 variants generally localize to the nucleus if they contain 
the nuclear localization signal. This is similar to the results of other studies conducted in 
yeast and HeLa cells (Semple et al. 2006; Ghosh et al. 2011). Orc6 is absent from the 
nucleolus, but otherwise shows an even, granular distribution in the nucleus without a 
clear preference for any chromatin environment. Similarly, Orc2 shows a granular 
nuclear pattern in all transfected cells, showing that mutant Orc6 does not alter its spatial 
organization. Endogenous Orc6 is still present in all cells however; therefore this could 
complement any effect the mutant Orc6 might have on Orc2 function. 
Compared to Figure 16 it is surprising that both variants lacking the C terminus show a 
wild-type signal, and generally co-localize with Orc2. 
The effect of the nuclear localization signal is even more striking. It is expected that 
deletion of the NLS results in the complete loss of the protein from the nucleus, but the 
results show more than that. Variant 6, containing the 11 amino acid deletion of the 
predicted consensus NLS is present in the cytosol as expected, in contrast to the nuclear 
wild-type protein. However, some of these proteins are still able to enter the nucleus and 
shows a near complete co-localization with Orc2, evidenced by the lack of red signal in 
the nucleus and the sole presence of yellow in the merge image. This means that despite 
losing its NLS, Orc6 can still enter the nucleus, most likely via forming a complex with 
ORC already in the cytosol, and traversing the nuclear membrane as part of a complex, 
not requiring a separate NLS. Although the formation of ORC prior to nuclear entry is 
not directly supported by this evidence, it is a surprising coincidence that an even larger 
deletion, as in the case of the Δ125-203 and the Δ50-203, will lead to a near-complete 
absence from the nucleus, showing prominent cytosolic signals. 
In conclusion this experiment provided unexpected results, as C terminus lacking Orc6 
variants showed similar localization as the wild-type protein, and their signals largely 
overlapped with those of Orc2. This is contradictory to the in vitro results presented in 
Figure 16 as there a clear loss of interaction is observed upon deletion of the C terminus. 
This means that in vivo, ORC assembly is different than in vitro. To further elucidate this 
interaction in vivo, and to characterize Orc6 function in the cell, a different experimental 
approach was required. 
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5.2 Functional analysis of Orc6 at 
origins of replication 
5.2.1 Orc6 variants are able to create origins of replication 
The previous experiments provided data on the mechanism of Orc6-Orc1-5 interaction, 
but no functional read out. The method used in this chapter addresses this with results 
that show if Orc6 is able to create functional origins of replication in living cells. 
The plasmid rescue assay introduced in chapter 2.4.1 allows in vivo analysis of 
replication competence of proteins. To carry out the experiment I inserted the seven 
variants introduced in Figure 14 into the pWHE vector, which adds a single chain Tet 
repressor domain (scTetR) to the N terminus of all constructs and allows eukaryotic 
expression of these fusion proteins (Krueger et al. 2003). In addition, I prepared the 
empty vector expressing the scTetR tag only as control. Using these vectors, I transfected 
HEK-293-D cells expressing EBNA1 and created cell lines which each stably express 
EBNA1 and one of the Orc6 variants. Next, I also introduced a wild-type oriP plasmid, 
an FR-TetO plasmid, or water to each of these cell lines. After carrying out the plasmid 
rescue assay I collected the results and summarized them in Figure 18. 
The goal of this experiment was to study the function of Orc6. Figure 18 shows the 
percentage of colonies counted with an FR-TetO plasmid, relative to the number of 
colonies obtained with a wild-type oriP plasmid in the same cell line. The higher the 
percentage, the more colonies were counted in the assay relative to oriP. This number 
depends on the replication efficiency of the plasmids, which in turn depends on the 
ability of the Orc6 variants to create functional origins of replication. Each experiment 
was performed in triplicates using newly thawn aliquots of each cell line. Figure 18 
displays the average number of colonies obtained in each setup, and their respective 
standard deviations. 
Both wild-type Orc6 and all variants, which I tested, provide around 2-10% as much 
colonies as EBNA1 with DS. The scTetR-tag only is strikingly different from these, as it 
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was not able to provide any colonies at all. All other variants yielded colonies in all 
experiments, showing that all Orc6 variants tested are able to create new origins of 
replication, including the full-length protein. This provides additional knowledge to 
previous experiments, where our lab has shown that full length Orc6 is able to generate 
new origins of replication (Thomae et al. 2011). An independent, unpublished thesis 
work made by Vishal Agrawal from the Gossen lab also confirmed these results. Albeit 
Orc6 is only about 5-10% as efficient as EBNA1 in facilitating replication, this activity is 
still sufficient to retain plasmids in human cells for up to a month when under selection, 
but the protein is likely to be able to carry out this function for even longer intervals. 
The results are in alignment with the microscopy data presented in Figure 17, which also 
underline that despite the mutations, Orc6 variants are able to co-localize with Orc2 and 
possibly function at origins. That result is now complemented with the functional readout 
of this experiment, which concludes that the variants are not only able to co-localize, but 
are also functionally active and are able to support replication initiation to about 5-10% 
of EBNA1. 
The plasmid rescue assay however is able to say more than that. Not only are these 
variants functionally active, but they are also able to establish an origin of replication, 
which is completely absent if they are not specifically directed to this site, as evidenced 
by the complete plasmid loss observed with the tag only. Surprisingly, all variants show a 
more or less similar replication activity, which is about a tenth of EBNA1. 
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Figure 18. Ability of Orc6 variants to create functional origins of replication. The protein constructs 
displayed on the left were expressed in HEK-293-D EBNA1 cells. Subsequently, these cell lines were 
transfected with the FR-TetO plasmid depicted at the top. The bars show the results observed upon 
performing a plasmid rescue assay with this setup in the individual cell lines. The percentage displayed is 
the ratio of colonies observed with the FR-TetO plasmid versus a wild-type oriP plasmid in the same cell 
line. N=3, error bars show standard deviation. 
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5.2.2 PR-Set7 is able to create origins of replication 
Seeing the positive results with Orc6 and its variants in creating functional origins of 
replication, I designed another experiment to test if this effect can be enhanced by also 
directing a histone methyltransferase to Orc6 dependent origins. Since Orc6 is only about 
5-10% as successful in replicating plasmids as EBNA1, a more favorable chromatin 
environment might be needed to boost this effect and lead to a more robust replication of 
plasmids in human cells, without the need for viral factors. To this end, I targeted PR-
Set7 to origins established by Orc6, and tested in plasmid rescue assays for plasmid 
maintenance efficiency. 
It has been established that PR-Set7 plays a role in origin activation by methylating the 
H4K20 residue locally on chromatin. This modification is required for proper S-phase 
replication initiation (Falbo & Shen 2009; Beck et al. 2012). H4K20 levels increase 
during G1, and diminish through S phase. This is linked to the cell-cycle regulated 
expression pattern of PR-Set7. The degradation of PR-Set7 is induced by the binding of it 
to PCNA in S phase (Tardat et al. 2010). 
To carry out the experiment, first I fused PR-Set7 to the Gal4 DNA binding domain 
(Gal4-DBD). This tag specifically targets the construct to GAL4 operator sites on DNA. I 
have also modified the reporter plasmids to carry GAL4 operator in the vicinity of the 
TetO sites (see Figure 17). Four new HEK-293-D cell lines were also created: one that 
expresses EBNA1, TetR:Orc6 and Gal4:PR-Set7, a second one with EBNA1, TetR:Orc6, 
Gal4-DBD, the third with EBNA1 and Gal4:PR-Set7 and a final cell line with EBNA1 
and Gal4-DBD. I transfected these four cell lines with either the FR-TetO plasmid, or the 
FR-GAL4-TetO reporter plasmid, and assayed them in plasmid rescue experiments. 
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Figure 19. Effect of PR-Set7 expression on Orc6 dependent plasmids. Four cell lines were generated 
from HEK-293-D EBNA1 cells by expressing combinations of scTetR:Orc6, Gal4:PR-Set7 or Gal4-DBD 
as displayed by the color-coded bars. These cell lines were transfected with the FR-TetO plasmid depicted 
at the top. Plasmid rescue assay was performed with this setup, resulting in the rescue efficiencies 
presented for each cell line. The percentage is a ratio of the FR-TetO plasmids rescued compared to wild-
type oriP plasmids rescued in the same cell line. N=3, error bars show SEM. 
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Results presented in Figure 19 show data obtained with an FR-TetO reporter, while 
Figure 20 depicts the same experiment using the FR-GAL4-TetO plasmid. As expected 
from the previous experiment, FR-TetO plasmids in cells expressing TetR:Orc6 show 
between 5-10% rescue compared to the wild-type oriP plasmid. This was not 
significantly changed by the ectopic expression of Gal4:PR-Set7 or Gal4-DBD, as these 
constructs are not targeted to the plasmid, and therefore are likely not involved in the 
rescue process, leading to similar results in the first two bars of Figure 19. 
When expressing, but not directing PR-Set7 to the plasmids, there is a slight increase of 
plasmids rescued compared to Gal4-DBD only, as evidenced by comparing the last two 
bars of Figure 19. This suggests that overexpressing PR-Set7 might influence the 
replication competence of reporter plasmids, even when not specifically directed to 
origins. The plasmid rescue experiments using the FR-GAL4-TetO reporter plasmid on 
the other hand showed different results. Targeting PR-Set7 to plasmids yielded a high 
rescue level (15%), but I observed no rescue with the tag only. This result suggests that 
PR-Set7 shows no combined effect when both it and Orc6 are targeted to the plasmid, as 
in this case, rescue is only 2-3%, staying in the range of that of the two proteins 
individually. This means that the presence of PR-Set7 does not increase Orc6 mediated 
plasmid rescue. Also, the histone methyltransferase induces replication activity on the 
reporter plasmid in this assay. This is in line with previous experiments where PR-Set7 
induced replication activity when targeted to a GAL4 operator cassette introduced into a 
chromosomal location (Tardat et al. 2010; Beck et al. 2012). 
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Figure 20. Effect of targeting PR-Set7 to Orc6 dependent plasmids. Cell lines expressing HEK-293-D 
EBNA1, and combinations of scTetR:Orc6, Gal4:PR-Set7 or Gal4-DBD as displayed by the color-coded 
bars, were used for this plasmid rescue assay. Contrary to the previous experiment, here the FR-GAL4-
TetO plasmid depicted at the top was used for the assay, allowing Gal4 mediated targeting of fusion 
proteins to the origin site. The resulting plasmid rescue levels are presented as a ratio of FR-GAL4-TetO 
plasmids rescued compared to wild-type oriP plasmids rescued in the same cell line. N=3, error bars show 
SEM. 
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5.2.3 PR-Set7 enhances existing replication origins 
The previous experiment indicates that targeted PR-Set7 induces replication. However, 
the impact of induced H4K20 methylation on an already existing replication origin is 
unclear. The experiments using the scTetR:Orc6 dependent origin did not show an 
increase in replication competence, therefore I wanted to determine if PR-Set7 has an 
impact on the more robust EBNA1 mediated replication initiation at the oriP origin. To 
test this I generated an FR-GAL4-DS plasmid, which, since it contains both the FR and 
the DS element of oriP, is only dependent on EBNA1 for efficient maintenance. Then I 
transfected the four cell lines from the previous experiment with this plasmid, and a wild-
type oriP plasmid as control. 
The experiment showed that PR-Set7 enhances EBNA1 dependent replication very 
efficiently, but only if TetR:Orc6 is not present in the cell. The tag itself has no detectable 
effect on EBNA1 function, whereas the histone methyltransferase can increase plasmid 
replication efficiency as much as tenfold if directed to EBNA1 mediated origins. 
Similarly to the previous experiment, if both PR-Set7 and TetR:Orc6 are expressed in the 
cell, plasmid maintenance efficiency is not increased, but reduced. Here, taking the wild-
type oriP plasmid as 100% in the same cell line, the FR-GAL4-DS plasmid could only 
deliver approximately half as many colonies in the rescue assay. 
In conclusion these experiments show information on the function of Orc6 and PR-Set7. 
Both can create new origins of replication, Orc6 is even able to do so if expressed as 
various truncated variants. Orc6 targeting to plasmids coupled with EBNA1 mediated 
plasmid retention forms a system which can stably maintain FR-TetO containing 
plasmids in human cells, independently of PR-Set7 mediated chromatin modification. 
PR-Set7, although being able to induce replication on its own, does not act in concert 
with Orc6 in the current experimental setup. 
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Figure 21. Effect of targeting PR-Set7 to EBNA1 dependent plasmids. Similarly to the previous 
experiment, here the same cell lines expressing EBNA1, and combinations of scTetR:Orc6, Gal4:PR-Set7 
or Gal4-DBD as displayed by the color-coded bars, were used for plasmid rescue assays. This time the FR-
GAL4-DS plasmid was tested, which is a solely EBNA1 dependent plasmid harboring GAL4 operator 
sites. The resulting plasmid rescue levels are presented as a ratio of FR-GAL4-DS plasmids rescued 
compared to wild-type oriP plasmids rescued in the same cell line. N=3, error bars show SEM. 
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5.3 Orc6 interacts with various other 
factors in the cell 
After characterizing the mechanics of Orc6 interaction with Orc1-5 and elucidating the 
function of the protein with the plasmid rescue experiments, I took a new approach to 
even better understand Orc6 in the human cell. Using immunoprecipitation coupled to 
mass spectrometry, I mapped the interaction network of HsOrc6. The idea behind this 
was to get information on the protein’s role outside replication initiation. 
So far, there have been no fully successful attempts in establishing the function of Orc6 
throughout the cell cycle. Orc6 has been seen already upon its discovery in humans to 
interact with unknown, non pre-RC proteins (Dutta & Dhar 2000). Further experiments 
showed that Orc6 depletion causes decreased replication, but also mitotic defects, 
multinuclear cells and multipolar spindles (Prasanth et al. 2002). The same effects were 
observed in Drosophila (Balasov et al. 2009), and avian cells (Bernal & Venkitaraman 
2011). The function behind these phenotypes in not yet fully elucidated, although it has 
been established that DmOrc6 interacts with septins and is involved in cytokinesis; and 
that ScOrc6 works together with Rrb1, the depletion of which also causing mitotic 
defects (Chesnokov et al. 2003; Huijbregts et al. 2009; Killian et al. 2004). 
To create the interaction network I immunoprecipitated Orc6 from nuclear extracts, using 
an Orc6 specific antibody covalently coupled to sepharose beads. As negative control, a 
non specific IgG antibody was employed. The positive control was an Orc2 
immunoprecipitation, the results of which were already published by another group (Shen 
et al. 2010). I loaded the precipitated proteins onto specially prepared, low contamination 
polyacrylamide gels and stained them with Coomassie dye after electrophoresis. Gel 
slices were analyzed by mass spectrometry (LC-MS/MS at the Zentrum für 
Proteinanalytik). After receiving the obtained spectra, I identified the proteins present 
using the Scaffold 4 software. I have made three replicates of each experiment, and 
statistically evaluated the results to rule out background and non-specific hits. I subjected 
the final list to DAVID, a functional clustering program, to identify proteins of the same 
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pathway or those involved in the same cellular mechanism. To complement this, I also 
conducted a study using the STRING protein interaction prediction tool. 
First, to test this experimental setup, I prepared an Orc2 immunoprecipitation and a 
corresponding IgG control, and analyzed it via mass spectrometry. This experiment was 
already conducted and published, and showed that LRWD1 interacts with ORC (Shen et 
al. 2010). 
Accession number Gene name IgG Orc2 
gi|5453830 ORC2 3 53 
gi|32483367 ORC3 2 52 
gi|32454746 ORC4 0 7 
gi|4505525 ORC5 0 32 
gi|23097240 LRWD1 1 49 
Table 1. Control experiment to identify known interactors of Orc2 via mass spectrometry. The table 
shows the number of total spectra obtained via mass spectrometry of an Orc2 immunoprecipitation versus 
IgG as control to test the validity of the experimental setup. The list of protein GI accession numbers and 
gene names only show members of the origin recognition complex, which were identified by this analysis. 
Although LRWD1 (OrcA) is not strictly a member of ORC, it was included as it was originally discovered 
using the same experimental setup in another study (Shen et al. 2010). Other factors identified are not 
shown, as they were also not reported in the Shen study, and therefore cannot be used to confirm the 
validity of this setup. 
My results fully confirmed the ones by the Prasanth lab. Total spectra of LRWD1, along 
with the core ORC subunits were enriched in the immunoprecipitation, and nearly absent 
in the IgG control. As I did this control experiment to test the efficiency of the method, it 
was not prepared in triplicates and therefore no statistical analysis was possible, but a 
robust difference is still present when comparing the immunoprecipitation to the control 
in Table 1. Although other factors were also enriched in this immunoprecipitation (data 
not shown), Orc6 was not among them, confirming the weak interaction between Orc6 
and Orc1-5. 
After confirming that the experimental setup is functional, I also carried out the Orc6 
immunoprecipitations, and subjected these to mass spectrometry. 
Scaffold 4 identified 1563 different proteins in the samples. A protein was considered 
identified if it had at least two unique peptides not present in any other protein, each of 
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the peptides was identified with at least 95% accuracy from the obtained spectra, and the 
protein itself was more than 99% accurately identified from these peptides. These rather 
stringent conditions ensure a low false positive rate, but also filter out many specific hits, 
since if a single unique peptide of a protein is present in the sample, then that protein is 
detected, but excluded from these results. 
From this list of proteins I collected the ones with spectrum counts significantly higher in 
the Orc6 immunoprecipitation samples than in the IgG control. Since the statistical 
method used here greatly influences the outcome of the experiment, I compared two 
different analysis methods.  
First, to get an overview I calculated a simple fold change: if a protein had at least twice 
as many total spectra in the Orc6 immunoprecipitation than in the IgG, and this was 
reproducible in all three replicates, then it was considered significant. To rule out infinite 
enrichments and divisions by zero, all values of zero spectra were replaced with 0.5. 
The strength of this analysis is its simplicity and the robustness of the members included. 
This method however does have weaknesses. The first of these is the inclusion of 
proteins with very few spectrum counts, since if 1-2 spectra were detected for the protein 
in the immunoprecipitation, and none in the IgG control, the protein would show up on 
this list, despite being on the detection limit in both samples. This is the case for factors 
like U1C or SFR2, which were barely detected in the immunoprecipitation, but because 
of the empty control, they are considered significant. The second limitation is excluding 
proteins, which have an unspecific binding to the beads or the control antibody. If such a 
factor provides a number of spectra in the IgG control, then it is more difficult to achieve 
twice as many in the Orc6 immunoprecipitations, so the protein might be excluded 
despite being an important interactor. Finally, experimental variance can also negatively 
affect the outcome of the analysis. If a protein does not meet the criteria in a single 
experiment, then it will be excluded, even if it provided robust results in the other two 
replicates. 
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Accession number Gene name IgG-1 IgG-2 IgG-3 Orc6-1 Orc6-2 Orc6-3 
gi|12056971 ANAPC1 0,5 0,5 0,5 2 1 6 
gi|15055539 RPS2 0,5 1 0,5 3 2 3 
gi|1840467 MSH2 3 1 0,5 8 2 5 
gi|22122445 CDC73 0,5 0,5 1 2 3 2 
gi|34582345 DDX52 0,5 1 0,5 1 5 3 
gi|37196760 EPPK1 2 0,5 1 4 1 7 
gi|40807443 PRC1 0,5 2 1 1 5 2 
gi|42476299 GIGYF2 0,5 2 1 2 7 9 
gi|4506619 RPL24 0,5 0,5 2 1 2 4 
gi|4507127 U1C 0,5 0,5 1 1 1 3 
gi|50659095 DDX21 0,5 1 0,5 1 2 1 
gi|52630326 CHD3 0,5 0,5 0,5 6 3 7 
gi|55666362 RPRD2 0,5 1 0,5 1 9 6 
gi|56676371 CPSF1 0,5 0,5 0,5 1 2 1 
gi|56757608 RFC1 1 1 1 3 4 4 
gi|57209883 PHF8 0,5 4 1 2 13 4 
gi|58331218 ARS2 3 1 1 6 2 3 
gi|6754472 KIF23 0,5 1 0,5 2 3 2 
gi|119609849 SFRS2 1 1 1 2 2 2 
gi|68533103 NUP153 0,5 0,5 0,5 1 1 1 
gi|71361682 NUMA1 3 7 10 10 18 22 
gi|4506691 RPS16 1 0,5 3 3 2 6 
gi|7657427 ORC6 0,5 0,5 1 6 21 21 
gi|7706501 WWBP11 0,5 0,5 0,5 1 2 2 
gi|8922712 SEP11 1 3 0,5 3 7 1 
Table 2. Factors identified by mass spectrometry with at least twice as many total spectra in all three 
Orc6 immunoprecipitations as in the control. Protein GI accession numbers and gene names are 
presented for proteins which were least twofold enriched in all three replicates in the Orc6 
immunoprecipitation over the IgG immunoprecipitation. The numbers indicate the amount of total spectra 
obtained for each protein in the respective sample. Values of 0 are exchanged to 0.5 to allow fold change 
calculations. Rows marked in bold show factors, which are also present in Table 3. 
Taking this into account I only used this protein list to get a quick overview of the 
proteins detected, and to check internal controls. This method yielded 25 hits, shown in 
Table 2, as significantly enriched proteins in the Orc6 immunoprecipitation over IgG. 
Orc6 as a positive control is present on the list with a high enrichment over background, 
and 15%, 39% and 25% sequence coverage in the three precipitations respectively. 
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However, other ORC subunits were not detected in the analysis, and also no pre-RC or 
pre-IC hits emerged. Since the Orc6-Orc1-5 interaction is weak and barely detectable 
with sensitive immunoblots, this is still acceptable, especially as the list shows various 
other factors which are enriched over the control. Also cell-cycle specific interaction 
might be weaker in the asynchronous extracts used. 
To use a more powerful statistical method to determine Orc6 interactors, Fisher’s exact 
test was also applied to the dataset with a p value cutoff at 0.05. As shown in Table 3, this 
yielded 61 proteins, one of the most significant hits being Orc6 itself, with a p value 
below 10
-4
 (Scaffold does not calculate exact p values below 10
-4
). No other ORC 
components were found to be significant even with this method. This larger protein pool, 
while containing more than twice as many hits as the fold change analysis, contains false 
positives as well, while only 15 proteins are present in both lists (these are marked in 
bold in Table 2). For example, three different keratins were included using Fisher’s exact 
test, although these show only a single spike in one of the samples, and do not provide 
reproducibly higher signals in all three experiments. As keratins are known as the most 
often appearing sample contaminations in mass spectrometry, despite being significant, 
they are likely to be false positives (Hodge et al. 2013). However for the integrity of the 
analysis and to use an unbiased approach, these are also included in the subsequent 
analyses. 
After obtaining this final list of possible interactors, the next step is to turn this data into 
information, and address the question ‘which other processes is Orc6 involved in besides 
replication initiation’. To achieve this, I used further tools of bioinformatics to 
characterize the functions of the proteins found, and to identify pathways and clusters 
from the list of hits. 
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Accession number Gene name IgG-1 IgG-2 IgG-3 Orc6-1 Orc6-2 Orc6-3 P value 
gi|158420731 CHD3 0 0 0 6 3 7 0,0001 
gi|33350932 DYHC1 10 4 4 21 7 40 0,0001 
gi|4506713 RPS27A 11 0 0 7 0 49 0,0001 
gi|7657427 ORC6 0 0 1 6 21 21 0,0001 
gi|119608214 SPTA 11 4 3 19 3 27 0,00017 
gi|119573938 RPRD2 0 1 0 1 9 6 0,00018 
gi|119595227 NUMA1 3 7 10 10 18 22 0,00038 
gi|1195531 KRT16 0 2 0 16 2 0 0,00048 
gi|156766047 GIGYF2 0 2 1 2 7 9 0,00098 
gi|119613715 EPRS 1 2 3 7 3 14 0,001 
gi|119610995 PRP8 2 4 1 8 2 15 0,0015 
gi|12056971 ANAPC1 0 0 0 2 1 6 0,0023 
gi|58530840 DSP 0 1 1 3 0 11 0,0026 
gi|116063573 FLNA 9 9 4 18 5 24 0,0028 
gi|62243332 MAD1 1 8 3 1 27 3 0,0039 
gi|119593672 POLDIP3 3 23 7 13 34 14 0,0043 
gi|32698700 PHF8 0 4 1 2 13 4 0,0043 
gi|33636719 TIM44 0 0 0 0 7 1 0,0045 
gi|15215421 VARS 1 2 0 6 2 7 0,0047 
gi|4758012 CLTC 7 1 3 10 1 17 0,0065 
gi|13654237 PRKDC 20 12 14 31 6 39 0,0074 
gi|12803709 KRT14 0 0 0 8 0 0 0,0089 
gi|14150141 PDCD2L 0 0 0 0 2 5 0,0089 
gi|21626466 MATR3 7 17 6 14 31 9 0,0092 
gi|119604485 DNMT1 2 3 5 10 3 12 0,011 
gi|119573397 GEF2 0 1 0 0 9 0 0,012 
gi|1840467 MSH2 3 1 0 8 2 5 0,012 
gi|34582345 DDX52 0 1 0 1 5 3 0,012 
gi|14719392 CFL2 11 0 0 9 0 18 0,013 
gi|54607053 GCN1 8 3 7 13 1 22 0,014 
gi|11935049 KRT1 6 13 15 26 13 18 0,016 
gi|119604500 RAVER1 5 23 13 13 36 17 0,016 
gi|101943240 TF3C-1 0 0 0 0 0 6 0,017 
gi|25777671 PPP1R10 0 0 0 0 4 2 0,017 
gi|27754056 TUBB6 0 0 0 0 0 13 0,017 
gi|119605748 TRAP1 3 3 3 4 2 16 0,019 
gi|37196760 EPPK1 2 0 1 4 1 7 0,021 
gi|15055539 RPS2 0 1 0 3 2 3 0,022 
gi|119585644 PBR1 1 0 0 1 2 5 0,022 
gi|4557365 BLM 0 0 1 0 4 4 0,022 
gi|61743954 AHNAK1 0 0 1 0 1 5 0,022 
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gi|119588370 ZNF289 0 5 0 2 13 0 0,025 
gi|4506787 IQGAP1 18 19 5 34 7 24 0,026 
gi|119568637 HDAC2 2 2 2 8 0 7 0,029 
gi|12803479 HNRNPUL1 0 0 4 5 1 7 0,029 
gi|119589485 TUBB4 21 26 0 30 17 24 0,032 
gi|119594342 DDB1 3 2 3 13 1 5 0,032 
gi|112382250 SPTB 11 1 9 15 4 18 0,033 
gi|119613328 RFC1 1 1 1 3 4 4 0,033 
gi|119568930 MDN1 0 0 0 1 0 4 0,034 
gi|7706501 WWBP11 0 0 0 1 2 2 0,034 
gi|12052826 RAB10 1 1 0 1 1 7 0,037 
gi|119571569 MYO18A 0 4 1 1 5 8 0,038 
gi|12017959 CDC73 0 0 1 2 3 2 0,039 
gi|13786127 CDC42EP4 1 9 7 7 14 10 0,039 
gi|20143967 KIF23 0 1 0 2 3 2 0,039 
gi|119614476 ANLN 6 10 5 8 10 18 0,042 
gi|126507451 CSE1L-2 1 1 2 5 1 6 0,045 
gi|40217847 SNRNP200 8 5 3 11 6 12 0,047 
gi|4503509 EIF3L 2 2 2 7 2 6 0,047 
gi|119574685 CCAR1 3 6 2 10 5 7 0,05 
Table 3. Factors identified by mass spectrometry from Orc6 and control immunoprecipitations with 
p values lower than 0.05 using Fisher’s exact test. GI protein accession numbers and gene names are 
presented for factors, which were significantly enriched in the Orc6 immunoprecipitation over an IgG 
control. The number of total spectra in each sample is presented for each protein, followed by the 
calculated p value. 
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5.3.1 Functional clustering of Orc6 interacting proteins 
The proteins identified in the previous chapter contain a number of interesting hits, but a 
list of 61 different proteins is hard to grasp. To overcome this, I used two different 
grouping methods to characterize the functions and cellular processes affected by the 
factors identified from the immunoprecipitation. 
First, I grouped the significant hits form the Orc6 immunoprecipitation according to gene 
ontology (GO) terms. GO terms are a set of popular, standardized keywords, describing 
gene product properties (Ashburner et al. 2000). For example in the GO Biological 
Process database, Orc6 is associated with two keywords: “DNA metabolic process” and 
“DNA replication”. 
For the grouping I used the online accessible DAVID (Database for Annotation, 
Visualization and Integrated Discovery) toolkit. DAVID is able to handle a gene list as 
input, collect the GO terms associated with the list members, and statistically analyze 
which terms are enriched compared to the human proteome as background using a 
modified Fisher’s exact test. This is done by the functional classification tool, which 
concluded that 46 out of 61 hits from the immunoprecipitation are associated with 
Biological Process GO terms, totaling to 63 statistically significant BP GO terms 
(p<0.05), using the standard settings for the program. Although these keywords help to 
better understand functions of the Orc6 interactors, they still build up to a large, 
complicated pool of keywords. To further refine this, DAVID also offers a functional 
clustering tool, which groups similar GO terms together into clusters, giving an overview 
of the biological processes Orc6 interactors are involved in. 
This analysis created 6 significant groups, shown in Table 4. The most prominent of these 
is the term “mitotic cell cycle” which shows by far the highest enrichment score. The 
score is the average –log10 of the p values of the cluster members, meaning that the 
average p value is 10
-4.17
 or 6.76×10-5 for the GO terms in the cluster of “mitotic cell 
cycle”. So the keywords similar to “mitotic cell cycle” are highly overrepresented in the 
list of immunoprecipitation hits, compared to the human proteome as background. The 
cluster itself contains keywords related to mitosis and cell cycle control. Both of these 
processes are expected for Orc6 interacting proteins, despite no other pre-RC components 
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were entered into the analysis. This result underlines the importance of the so far poorly 
understood mitotic function of Orc6, which was first observed in human cells by the 
Prasanth lab more than a decade ago, but still remains uncharacterized (Prasanth et al. 
2002). Proteins like the Bloom syndrome protein (BLM), Mitotic arrest deficient-like 1 
(MAD1), Nuclear mitotic apparatus protein 1 (NUMA1), Anaphase promoting complex 
subunit 1 (ANAPC1) are among the most prominent interactors of Orc6, while even 
mitosis related scaffolding proteins like Septins (SEPTA, SEPTB) and Anillin (ANLN) 
are present in the list. 
 
Cluster with most significant gene ontology term Enrichment score 
mitotic cell cycle 4.17 
macromolecular complex assembly 2.19 
negative regulation of organelle organization 1.78 
cellular protein localization 1.72 
RNA splicing, via transesterification reactions 1.55 
DNA metabolic process  1.32 
Table 4. Functional annotation clusters of Orc6 immunoprecipitation hits. This table contains 
biological process GO term clusters significantly enriched among Orc6 interaction partners compared to the 
human proteome as background. Each of the six clusters contains GO terms similar to the name of the 
cluster. The enrichment score is the combined (-lg) p value of the respective cluster’s individual GO terms. 
The other expected group, the “DNA metabolic process” cluster is still considered 
significant for this study, with an enrichment score of 1.32 (p=0.047). This contains 
keywords connected to DNA repair, and cellular stress response. Orc6 being an efficient 
DNA binder, part of the pre-RC, and a known CDK target fits well into this group, and 
may have a yet to be pinpointed role in cell cycle control upon DNA damage. 
The rest of the keywords in Table 4 are less meaningful in a biological way. 
“Macromolecular complex assembly” is attributed to proteins, which form larger 
complexes. As this is a common feature for many proteins from tubulins to ORC itself, 
this keyword cluster has little value interpreting the functions of Orc6 interactors. 
Similarly, “negative regulation of organelle organization” denotes proteins, which are 
involved in the disassembly of any structure in the cell, like protein complexes, cellular 
components or the cytoskeleton. Again, this general term can mean different things 
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depending on the context, and therefore has little value. “Cellular protein localization” is 
a keyword cluster containing GO terms of protein import, transport, targeting and 
localization, and other similar keywords. This can mean transcription factors, DNA 
damage cascades or signaling pathways alike, anything which involves the localization of 
proteins. As the term does not identify the type of pathway these proteins are involved in, 
this biological process is yet again a too general attribute of Orc6 interacting proteins. 
Lastly however, “RNA splicing” is an unexpected, interesting cluster. It contains 
keywords, which are connected to transcription and the processing of mRNA. 
Transcription related proteins are present in the immunoprecipitation hits, but so far Orc6 
has not been connected to transcription. Looking at the interacting gene names hnRNP-
UL1, CCAR1, WBP11, PRPF8 and SNRNP200 (snRNP-U5) are all transcription related 
gene products. They are however involved in very different processes, and although Orc6 
has been shown to be involved in ribosome biogenesis (Killian et al. 2004), transcription 
related functions of this protein are not known from other studies to date. 
Apart from the DAVID analysis, I also used an independent method to integrate Orc6 and 
its newly found putative interactors into cellular pathways. For this I used the STRING 
program, which offers to map known interactions between proteins and to predict new 
ones (Franceschini et al. 2013). It uses the genomic context of genes, published high 
throughput experiments, co-expression data and also mines the text of scientific 
publications to gather knowledge on protein interactions. Using this data, it takes a list of 
input proteins, and assembles them into networks. Factors taken from Table 3 are 
assembled into the network presented in Figure 22. 
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Figure 22. STRING network analysis of Orc6 interaction candidates. Interaction network generated 
from the list of Orc6 immunoprecipitation hits by the STRING-DB algorithm using its standard settings 
(Franceschini et al. 2013). Out of the 61 input factors 32 are displayed which had at least one connection to 
another factor. The links between the proteins are color coded as shown in the bottom right. The 8 clusters 
marked in red indicate proteins involved in similar processes. 
Out of the 61 members, STRING found 32 that had a connection to at least one other 
factor. The interaction map displays one mayor cluster with 21 factors (groups 1, 6 and 
1
5
7
2
4
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8
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8), one with 3 (group 7), and 4 other clusters with pairs of proteins in each one (groups 2-
5). The main cluster can be divided into three subgroups as presented in Figure 22.  
Analyzing these 8 groups in detail, group 1 contains transcription factors, similarly to the 
“RNA splicing” cluster identified by DAVID. All five proteins from the “RNA splicing” 
cluster are present in group 1, with GCN1, GIGYF2 and DDB1 added to them. GCN1, 
based on its Uniprot identifier (Q92616) is factor involved in transcription control, and 
has been most extensively studied in yeast. Based on this function, it fits to other 
members in this group. GIGYF2 on the other hand is a poorly characterized protein, with 
no function known to date. It was shown in two separate studies to be involved in either 
insulin-like growth factor signaling (Giovannone et al. 2003) or Parkinson’s disease 
(Lautier et al. 2008). However, the former study only presents evidence on GIGYF1, a 
related, but different factor, and only in yeast. And the Lautier paper was challenged by a 
follow up study, which found no connection to Parkinson’s. The reason why it is included 
in the group is its published interaction with PRPF8 and WBP11 which was conducted 
during a study of yeast mRNA processing pathways (Ash et al. 2010). A further 
connection to WBP11 is found in a paper detailing GYF domain function, using GIGYF2 
as an example (Kofler et al. 2005). Based on the little evidence available on this protein, 
it may be involved in mRNA processing, and therefore might fit to the group of splicing 
factors. Finally, DDB1, although predicted to be part of the mRNA processing group, is 
in reality a factor involved in DNA repair, which is why it was included in the “DNA 
metabolic process” cluster in the DAVID analysis. The reason why it is connected to 
PRPF8 is that these two proteins were found to be co-expressed in a Drosophila mitosis 
study, and in another paper on macrophage transcription regulation (Somma et al. 2008; 
Patino et al. 2006). More importantly, DDB1 is known to attach to p21, and p21 levels 
are shown to be affected directly by Orc6 activity in human colon cancer cell lines 
(Abbas et al. 2008; Gavin et al. 2008). 
Group 2 contains two members of the septin family. These proteins are required for 
cytokinesis by providing the scaffolding required for chromosome segregation and cell 
division. Their depletion leads to mitotic defects, similarly to those of Orc6 (Spiliotis et 
al. 2005), also a study from Drosophila indicates that Orc6 interacts with Pnut, a member 
of the septin family. Similarly, group 3 and 5 also contain structural proteins. Although 
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the role of septins fits well into the profile of Orc6, desmoplakin (DSP) and the three 
keratins should be evaluated with caution. Structural proteins are often present in large 
numbers in cellular extracts, and can also be present as contamination in the samples as 
discussed in the previous chapter. Since I found no other evidence in literature of Orc6 
interacting with keratins, groups 3 and 5 will not be discussed in more detail. 
Group 4 on the other hand fits well to a proposed role of Orc6 in ribosome biogenesis 
(Killian et al. 2004). Both RPS2 and RPS27A are part of the 40S ribosomal subunit 
(Kenmochi et al. 1998), and provide the long sought link between ORC and ribosome 
biogenesis (Thomae et al. 2008). 
Looking at group 7, the last small group identified by STRING, leads again to mitosis. 
The two tubulin genes (TUBB4 and TUBB6) and ARHGEF2, a GTPase, all take part in 
microtubule formation (Ren et al. 1998). Experimental evidence confirming the 
interaction of Orc6 with microtubules comes from microscopy experiments, which 
showed that Orc6 localizes to the midbody, which is itself made up of bundles of 
microtubules (Skop et al. 2004). ANLN and KIF23, although present in group 6, are also 
related to this process: the former is a scaffolding protein required for cleavage furrow 
formation (Oegema et al. 2000), while the latter is a plus-end directed microtubule-
dependent motor protein expressed in mitosis (Nislow et al. 1992). 
Finally looking at groups 6 and 8, they essentially form one larger cluster, which I 
divided into two small subgroups. The reason behind the splitting is that group 8 contains 
a well-characterized assembly of proteins, whereas group 6 is more heterogeneous. In 
group 8, DNMT1 and HDAC2 are both widely studied epigenetic factors, involved in 
transcriptional regulation, DNA damage response and DNA replication (Jin & Robertson 
2013; Krämer 2009). The two factors have also been published to interact with each other 
in several independent studies from both man and mouse (Rountree et al. 2000), HDAC2 
was also shown to bind to MAD1, an important mitotic regulator (Yoon et al. 2004; 
Rottmann et al. 2005), and CHD3, a member of the Mi2/NuRD chromatin remodeling 
complex (Hakimi et al. 2002; Kunert et al. 2009). 
Group 8, in contrast to group 6, contains a more disperse pool of DNA replication and 
repair related proteins, which do not associate to a single pathway. Most of the links 
between the factors within are marked with black color, indicating similar coexpression 
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patterns in different organisms, but no direct functional link. However, looking at the 
individual members, BLM, RFC1 and ORC6 are all involved in different aspects of DNA 
replication. The direct interaction proposed by this analysis would hint at a cooperation of 
these proteins in replication control. Repair proteins are represented by MSH2, a central 
member of the cluster, which is also a post-replicative DNA mismatch repair protein and 
oncogene (Iaccarino et al. 1998). Secondly, the product of the PRKDC gene is a crucial 
component of double-strand brake repair. Lastly, there are two hits which are functionally 
unrelated to the other members of the group, and are likely to be experimental artifacts: 
CSE1L is a member of the nuclear importing complex, and EPRS is an aminoacyl tRNA 
synthetase. 
In summary, the results in Table 4 and Figure 22 introduce novel interactors of Orc6 and 
connect this protein to various cellular processes other than DNA replication. From the 
interaction network Orc6 appears as a prominent mitotic factor, likely to be involved in 
multiple aspects of this process, and is also linked to ribosome biogenesis and DNA 
repair. 
6. Discussion 
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6.1 Orc6 is an abundant ORC 
component 
Before any analysis of Orc6, my priority was to ensure that this factor is readily 
detectable and present in the studied cell types. For this, I quantitated Orc6 levels in the 
cell lines used, which allowed subsequent experiments by showing a clear presence of 
this protein in my samples (Figure 5). 
Looking at the data in this figure, it is apparent that Orc6 is about ten times more 
abundant in the cell than Orc2. Given that ORC itself contains exactly one of each 
subunit (Sun et al. 2012), Orc6 shows no sign of degradation as opposed to Orc1 (Ritzi et 
al. 2003), and Orc6 saturates on DNA even more quickly than Orc2 (Figure 10), it would 
be expected that Orc2 and Orc6 are expressed to similar levels. Since Orc6 is about 
tenfold more abundant than Orc2, this either means that large amounts of Orc6 are 
needed for the Orc6-Orc1-5 interaction, or that Orc6 might have additional functions for 
which the other molecules are required. The former scenario is less probable, as literary 
evidence from knock-down of Orc6 in HeLa and human colon cancer cells states that a 
five-fold reduction of Orc6 levels still supports replication, but leads to polyploidy and 
multinucleated cells (Prasanth et al. 2002; Gavin et al. 2008). This means that pre-RC 
formation and replication initiation is still possible with decreased Orc6 levels. However, 
the less well understood mitotic functions become defective if protein levels are reduced. 
Based on this, the excess Orc6 seen in Figure 5 is indeed required for the suspected non-
pre-RC related functions of this factor.  
To further support this, using knowledge from literature it can even be estimated how 
many Orc6 molecules are actually required for replication initiation. The following 
calculation is not accurate, but it aims to estimate the number of ORC molecules in a 
human cell according to the current models: 
There are approximately 30.000 replication forks in a human cell (Nasheuer et al. 2002; 
Aladjem 2007) these would require half as many functional pre-RCs, due to the 
bidirectional nature of human DNA replication. Furthermore, the number of assembled 
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pre-RCs are assumed to be significantly higher than the actual origins that fire every cell 
cycle, with approximately 10-20% pre-RCs used in each S phase (Papior et al. 2012). 
This would mean that according to current models, at least 75.000 ORC molecules are 
expected to be present in every cell at pre-RC sites alone, not including protein turnover 
or other cellular processes. 
After this theoretical calculation, looking at the experimental data in Figure 5 again, Raji 
cells contain 14.5495 femtomole Orc2 molecules per million cells. Calculating from this 
would lead to 8730 Orc2 molecules in a single Raji cell, while for HEK-293-D cells this 
number is 20929 according to the quantification results. Of course the accuracy of 
quantified immunoblots is not expected to be this high, so these results should not be 
treated as hard numbers. Instead, the magnitudes of these numbers are more meaningful: 
there are around 1x10
4
 and 2x10
4
 Orc2 molecules in Raji and HEK cells respectively, 
which is in the ballpark of the 7x10
4
 theoretical estimate, albeit nearly a magnitude lower. 
This is either due to the inaccuracy of the model, which is still lacking quantitative results 
despite concentrated efforts (Schepers & Papior 2010), or the experimental setup. 
Possible fallacies in the latter include the inaccurate measurement of the purified 
proteins, cell-counting deviations, and extract preparation and sample handling errors. 
Still, the same measurement yielded around 2x10
5
 Orc6 molecules per cell (207634 in 
Raji and 181703 in HEK-293-D), which is in range of the predicted amount and possibly 
more. 
These results fit well to a similar quantification study, which found 7.5x10
4
 Orc2 
molecules per cell in the hamster CHO cell line, and also showed that Orc4 and 5 are 
expressed to similar levels (Wong et al. 2011). The obtained data also confirm that Orc6 
is an abundant ORC component in the cell, which enables it to take part in multiple 
cellular processes. This also serves as the first step in characterizing Orc6, as its 
abundance allows all subsequent analyses. 
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6.2 Orc6 has two distinct ways of 
attaching to Orc1-5 
The excess Orc6 discussed in the previous chapter may have multiple functions. As I 
outlined in the aims of the project, I started the characterization of Orc6 by looking at the 
mechanism of its attachment to Orc1-5, and its DNA binding ability. 
I have found that since Orc6 is able to bind a DNA segment as small as 200bp (Figure 9), 
without the aid of other ORC components (Figure 11 and Figure 12), it might firstly act 
as a protein that helps direct pre-RC factors to DNA. In other words, according to the 
experimental evidence presented in this work, Orc6 might be able to create binding sites 
for ORC. This is supported by Figure 18, which shows that Orc6 alone is able to create 
functional origins of replication if targeted to specific sites on chromatin. This is possibly 
achieved by recruiting Orc1-5, or other pre-RC factors to itself to allow replication 
initiation. This suggests that the abundance of Orc6 might be required to bind sites for 
future pre-RC assembly. Since Orc6 is more abundant than Orc1-5 and it is able to bind 
DNA without the aid of other ORC components, it might bind several possible origins, 
which then compete for Orc1-5. This mechanism would be similar to that of ORC itself, 
which attaches to DNA at several sites, but only some are able to recruit the complete 
pre-RC in each cell cycle (Papior et al. 2012).  
Secondly, Orc6 is able to form a complex with Orc1-5 and Cdc6 already before DNA 
binding (Figure 6), and binds as the holocomplex to DNA. This means that the Orc1-5-
Orc6 interaction can occur both on DNA and in solution. The two mechanisms converge 
on the point where ORC is assembled on DNA.  
Figure 11 and Figure 12 approach the two-way binding mechanism from a different 
perspective. These figures provide evidence on Orc6 forming a complex with Orc1-5 on 
DNA or in solution. Here, the two experiments show that the absence of Orc1-5 lessens 
Orc6 binding, as the Orc6 signal is weaker in the Orc2 depleted lane than in the IgG 
depleted lane. Secondly, adding excessive Orc6, but not BSA to the plasmid-binding 
assay enhances Orc2-DNA binding. So the binding of Orc2 and Orc6 to DNA mutually 
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enhance each other, while the two proteins are still able to bind DNA in the absence of 
another to a lesser extent. Given that I also show the complete ORC-Cdc6 complex in 
solution in Figure 6, a convenient explanation for all these experiments would be that 
Orc6 is able to bind Orc1-5 both on DNA and in solution. This model extends our 
knowledge on the so far poorly understood Orc6-Orc1-5 interaction and is also supported 
by a another study published while this project was in progress (Ghosh et al. 2011). 
6.3 Orc6 has domains that control 
cellular localization and ORC 
interaction 
In order to better understand the mechanisms of Orc1-5 attachment and DNA binding of 
Orc6 outlined in the previous chapter, I also conducted domain mapping analyses, 
especially because other publications on this topic reported contradicting results to date. 
Although there are three studies published exploring Orc6 domains, none of them 
provided the full picture. First, a study was conducted in Drosophila using Orc6-S72A, 
Orc6-K76A and Orc6ΔC (Balasov et al. 2007). In another publication, a systematic 
domain mapping was performed using HsOrc6 with regards to cellular localization, along 
with the study of the predicted phosphorylation site at T195 (Ghosh et al. 2011). The 
final publication in this respect was the crystallization of the middle of Orc6, which 
identified Q129, R137 and K168 crucial for DNA binding (Liu et al. 2011). 
These studies provide valuable information, but an incomplete picture of Orc6 domains. 
DmOrc6 for example proved to function differently than HsOrc6. DmOrc6 is 
indispensable for ORC-DNA binding in fruit flies, a feature distinct from any other 
species observed. The S72A and K76A mutations, although proven to be required for 
DNA binding of Orc6 in drosophila, had no such effect in human proteins (see Figure 17 
and data not shown). Also, the C terminal deletion mutant in Drosophila presented no 
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change in binding to Orc1-5, contrary to Figure 16. A possible explanation for the 
different behavior is the large evolutionary distance between HsOrc6 and DmOrc6. As 
seen in Figure 23, HsOrc6 is most closely related with its homologues in primates, and 
other vertebrates. Insects however, are very distantly related to this group, and are even 
further away than the Orc6 proteins of plants, despite both insects and primates being 
metazoans. Therefore, the large evolutionary distance between DmOrc6 and HsOrc6 can 
account for the observed difference in the effect of mutants. 
Contrary to the Drosophila study (Balasov et al. 2007), my results confirmed, and further 
developed the findings of the two 2011 papers on this topic (Liu et al. 2011; Ghosh et al. 
2011). Namely I confirmed the activity of the consensus nuclear localization signal of 
Orc6 studied by the Ghosh laboratory (Figure 17), and provided evidence that S72 and 
K76 do not affect DNA binding in humans as stated in the Liu paper (Figure 18 and data 
not shown). Further, I identified a new domain of Orc6: the Orc1-5 interaction domain in 
the C terminus (Figure 16). This was achieved by first creating 7 different Orc6 
derivatives (detailed in Figure 14) and testing their nuclear localization (Figure 17), 
interaction with Orc1-5 in vitro and in vivo (Figure 16 and Figure 17, respectively) and 
ability to create origins of replication (Figure 18). 
Concluding these experiments, I have established that Orc6 requires its C terminus to 
interact with Orc2 in vitro. Surprisingly, C terminal deletion does not alter the nuclear 
localization of Orc6, it even co-localizes with Orc2 in vivo despite the absence of 
interaction in vitro. A possible explanation for this observation is that although Orc6 
requires its C terminus to interact with Orc1-5 directly, an indirect interaction through 
another domain might still be possible in vivo via additional factors present at the pre-RC. 
These hypothetical proteins which help recruit Orc6 to the pre-RC in vivo are likely to be 
missing from the in vitro origin recognition complex, as even ORC-Cdc6 complexes are 
challenging to assemble in solution (see Figure 6). 
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Figure 23. Evolutionary conservation of Orc6. Homologues of the HsOrc6 protein sequence were 
identified by BLAST, and plotted using the built-in distance tree option, with the recommended settings for 
both programs (McGinnis & Madden 2004). The branch lengths correspond to the sequence divergences of 
each node from their hypothetical common ancestor using the fast minimal evolution algorithm (Desper & 
Gascuel 2004). The tree is rooted in the middle of the longest branch. For this image, model organisms and 
species representing large taxonomic groups found were chosen out of the total 112 HsOrc6 homologues 
found. 
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Looking at the microscopy experiments in more detail, evidence can be found for this 
second proposed pre-RC binding site of Orc6 being at AA125-181. In Figure 17 the 
AA125-203 deleted construct is present largely in the cytosol, similarly to the AA50-203 
deleted variant. Surprisingly, removing only the nuclear localization signal (AA181-200) 
leads to an only partially cytosolic localization, with the remaining nuclear Orc6 co-
localizing with Orc2. This means that missing AA125-181 changes cellular localization 
of Orc6 from partially cytosolic to dominantly cytosolic. Since I reason in the previous 
chapter that the ΔNLS mutant is still able to enter the nucleus in complex with other 
factors, the combined deletion of the NLS and AA125-181 might block the binding of 
other factors to Orc6, leading to the observed dominantly cytosolic localization. The area 
AA125-181 is a prime candidate for pre-RC interaction, as it also contains the α3-α6 
helices and all three essential amino acids required for origin binding of HsOrc6 (Liu et 
al. 2011).  
 
Figure 24. Model of HsOrc6 interaction and localization domains. Model depicting the results of Orc6 
domain mapping experiments with the scale on top representing amino acids in the protein. In vitro, the C 
terminus (AA203-252) is required for Orc6-ORC interaction. In vivo, deletion of the C terminus has no 
effect on Orc6 localization, therefore another domain must be also responsible for Orc6-pre-RC interaction. 
N terminus deletion also has no G1 localization phenotype. Deletion of the consensus NLS sequence leads 
to partially cytosolic presence, while deleting AA125-203 or AA50-203 shows a prominently cytosolic 
localization. Based on these results, the second Orc6 targeting domain might be present in the AA125-181 
region, which has already been shown to be important for DNA binding (Liu et al. 2011). 
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Another explanation could be that despite AA181-200 having a consensus NLS signal, a 
second NLS is present at AA125-181, or the observed signals might simply be 
overexpression artifacts. However, a previous study already tested the former possibility, 
and found no change in localization if a small deletion was present anywhere in the 
AA125-181 region, but also found a similar, only partially cytosolic localization 
phenotype if the consensus NLS sequence was removed (Ghosh et al. 2011; Kalderon et 
al. 1984). 
In conclusion, my results show that the C terminus of Orc6 is required for direct 
interaction with ORC, and I also found evidence of a second pre-RC binding site, which 
might be located in the region AA125-181. For nuclear entry, Orc6 uses its own NLS, but 
in the absence of this, it is still able to localize specifically to Orc2 in the nucleus via 
other means, possibly by its additional pre-RC interaction domain. These experiments, 
together with the previous chapter, conclude the mechanical analysis Orc6-ORC and 
Orc6-DNA interactions, completing the first goal of this study. 
6.4 Derivatives of Orc6 are sufficient 
to create origins of replication 
Moving on from the first goal of this project which deepened our knowledge on the 
mechanical interactions between Orc6 and ORC, and the impact of this interaction on 
DNA binding, I continue by addressing the second set of problems outlined in the aim of 
this study. Here, I summarize my results on Orc6 function in the living cell. 
Although in a previous paper our group has already shown that Orc6 is able to create 
functioning origins of replication (Thomae et al. 2011), this study further elucidates that 
even parts of the protein are sufficient for this process. In fact, all Orc6 derivatives tested 
were able to create weak, but functional origins of replication, as seen in Figure 18. This 
is possibly the consequence of Orc6 having two separate pre-RC interaction domains, as 
discussed in the previous chapter. All the Orc6 variants tested had at least one of these 
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intact (either the C terminus or AA125-181), so they should interact with pre-RC factors 
despite mutations or deletions in other domains. Since targeting was achieved by the 
fused scTetR tag, no DNA binding ability was necessary for the Orc6 part itself. 
Therefore it is no surprise that all seven variants tested provided similar amounts of 
rescued plasmids. Although minor differences are present between the constructs, these 
are not robust enough to be conclusive. 2-3% differences are not justified from the 
experimental setup; therefore I consider all constructs equally effective in inducing 
replication. However, I do consider the highly reproducible 0 colony result of the tag only 
construct to be markedly different from the 1-2% replication, as here the difference 
means either not replicating at all, versus inducing replication. Therefore the negative 
control is clearly surpassed by all constructs tested. 
It could also be argued that any protein with a certain minimum length can support 
replication. This however was disproven by our lab previously when we showed that 
certain variants of HMGA1a are able to support replication, but not others (Thomae et al. 
2011). 
Despite the Orc6 constructs being on average around 20 times less efficient in inducing 
replication than EBNA1, I still conclude that Orc6 is sufficient in inducing replication on 
plasmids, and even derivatives of the protein are able to do so, as evidenced by often 
hundreds of plasmids recued after each assay. Therefore, linking parts of HsOrc6 to 
scTetR is a possible way to create self-replicating plasmids for use in gene therapy.  
Attempts at boosting replication efficiency by co-targeting PR-Set7 to the initiation sites 
have not been successful. PR-Set7 alone, and Orc6 alone are able to induce replication on 
plasmids, but no combined effect is observed. A possible explanation for this is that oriP 
is bent and twisted during the initiation process, and then melted during pre-RC 
formation (Bashaw & Yates 2001). In the presence of one targeted protein, this is 
apparently still possible, but if two tagged fusion proteins are targeted to the site, steric 
hindrance might disallow efficient replication initiation. Still, Figure 20 and Figure 21 
show that although PR-Set7 is not able to boost Orc6 replication competence, it is alone 
able to induce replication initiation, and can boost EBNA1 dependent replication 
initiation if tagged Orc6 is not present in the assay. 
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In conclusion, this study found that Orc6, and its derivatives, can function in the cell by 
creating origins of replication. These origins are independent of the newly found PR-Set7 
mediated replication initiation. These results shed more light on Orc6 function and fulfill 
the second goal of this project. 
6.5 Orc6 is a versatile cell cycle 
regulation factor 
After discussing the mechanical interaction between Orc6 and members of its complex, 
and studying how the protein works in vivo, I set out to meet the final goal of this project 
and map the interaction network of the protein to find new pathways it is involved in. 
The fact that HsOrc6 is involved processes outside replication initiation was already 
proposed upon its discovery (Dutta & Dhar 2000). Shortly afterwards it was shown by 
microscopy that depletion of Orc6 from human cells causes defects in G1 but has even 
bigger effects in mitosis (Prasanth et al. 2002). The results presented in this thesis further 
underscore the importance of these findings, and characterize Orc6 not as a dominant 
factor in pre-RC formation, but a more versatile nuclear component also involved in cell 
cycle regulation. 
By employing immunoprecipitation coupled to mass spectrometry, I was able to identify 
a large number of Orc6 interactors, the final list of which are shown in Table 3. From the 
list, pre-RC factors are mostly missing. This surprising result is probably due to the weak 
interaction between Orc6 and Orc1-5. Supporting this, doing the same experiment using 
Orc2 I was able to clearly identify most ORC components (Table 1), and even LRWD1 
(OrcA), a pre-RC related factor originally indentified by the same approach in another lab 
(Shen et al. 2010), but not Orc6. 
As the expected hits were not present in the Orc6 hit list, but many other factors were, I 
employed grouping algorithms to identify cellular processes and pathways that are 
connected to these factors. Both functional clustering (Table 4) and STRING network 
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analysis (Figure 22) concluded that interacting factors are mostly related to cell cycle 
control. Visualizing this using DAVID’s built-in KEGG pathway finder, yet again the 
cell cycle related proteins were identified as the only and highly enriched group of 
identified proteins. 
 
Figure 25. KEGG pathway map with significant hits from the Orc6 immunoprecipitation. Using the 
list of identified and statistically significant proteins of the Orc6 mass spectrometry analysis, the DAVID 
functional annotation tool identified one group of proteins from the KEGG (Kyoto Encyclopedia of Genes 
and Genomes) database. The cell cycle protein group contains crucial pathways for cell proliferation 
control. The factors marked by a red star indicate the proteins directly present among Orc6 interactors. This 
pathway was identified by DAVID’s standard settings with a p value of 0.0029. 
The pathway map of Figure 25 I included here in the discussion as it not only shows the 
relevant hits and the connecting process, but also displays the pathways Orc6 is linked to 
in cell cycle control. In early G1 (until early S phase) it is involved pre-RC formation 
although connecting factors like other ORC components or Cdt1 are not marked in the 
image. Next, detailed under S phase, are the damage checkpoint pathways, also crucial 
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elements of cell cycle control and G1/S transition. Here, Orc6 interacts with the product 
of the PRKDC gene (shown as DNA-PK), which is a crucial factor for double strand 
break repair, and also recombination. Although not present in the image, the bloom 
syndrome protein (BLM) is another interacting partner of P53 and Orc6, and is also 
involved in managing recombination, hinting at a role of Orc6 in DNA repair. 
After S phase, numerous mitotic factors are present in the interaction list, establishing 
mitosis as the most prominent cellular process identified among Orc6 interactors. 
Although only ANAPC1 (APC/C) and MAD1 are present in the image, septins (SEPTA, 
SEPTB), anillin (ANLN), NUMA1, and CHD3 are all present on the list, and are mostly 
involved in chromosome segregation and cytokinesis. 
Apart from cell cycle control proteins some other identified interactor groups provide 
hints at more distinct functions. Epigenetic factors for example are among the most 
interesting candidates on the list. There are 3 histone modifying enzymes found: CHD3, 
HDAC2, and PHF8. Not only are these all epigenetic factors and involved in cell cycle 
control (CHD3 in cytokinesis (Hakimi et al. 2002), HDAC2 in ORC expression (Wang et 
al. 2001), and PHF8 replication initiation and G1-S transition (Liu et al. 2010)) but they 
are all involved in X-linked mental retardation, one of the most common causes of mental 
retardation in males (Hakimi et al. 2003; Ropers & Hamel 2005; Loenarz et al. 2010). As 
Orc6 itself is linked to developmental diseases (namely the Meier-Gorlin syndrome (de 
Munnik et al. 2012)) it would be interesting to pursue Orc6’s function in human 
development. 
PHF8 itself is especially interesting for this study, as it demethylates H4K20 residues, the 
same residues which are methylated by PR-Set7 (Beck et al. 2012), and which have been 
shown to affect replication initiation (see chapter 5.2.2, 5.2.3, and (Liu et al. 2010)). 
Also, PHF8, along with HDAC2 has been shown to regulate E2F mediated transcription 
(Jung et al. 2012; Liu et al. 2010), which pathway is responsible for the expression of 
ORC components (Diaz-Trivino et al. 2005). Therefore this interaction might foretell a 
feedback loop regulating Orc6 expression during the cell cycle.  
Looking at the patterns emerging from Orc6’s interaction network I conclude that instead 
of considering Orc6 as a pre-RC factor, it should be regarded instead as a multifunctional 
protein involved in various aspects of cell cycle regulation. 
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In summary, I provide experimental data and a model to elucidate Orc6-Orc1-5 
interaction by demonstrating that complex assembly might occur in solution and on 
DNA, and is dependent on the C terminus of Orc6. I also explore Orc6 function and 
conclude that the protein itself, and truncated constructs derived from it are able to create 
functioning origins of replication. Finally I place Orc6 into a new context by 
demonstrating a rich interaction network of this multifunctional cellular factor. 
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7. Summary 
Orc6 is a crucial component of the replication initiation machinery in eukaryotes. Its 
study helps us to better understand one of the most basic cell functions: DNA replication. 
The first step in replication initiation is the assembly and DNA binding of the origin 
recognition complex (ORC). Although members of ORC are highly conserved and well 
studied, Orc6 evolved faster than the other members of the complex, has a different 
structure and is less well understood than Orc1-5. The low number of studies on Orc6 in 
human cells and the low predictability of results obtained from model systems 
necessitates an in depth analysis of HsOrc6. 
The aim of this study is to better understand the role of Orc6 in the human cell by 
exploring the mechanism of Orc6-Orc1-5 interaction and Orc6-DNA binding, studying 
the function of Orc6 in live cells, and mapping its interaction network to find new 
pathways and functions of the protein. 
The study concludes that Orc6 interacts via its C terminus with Orc1-5 in vitro. It might 
also have a second pre-RC interaction domain, probably close to the nuclear localization 
signal. Orc6 is not required for Orc1-5-DNA binding, but is able to enhance the process 
in vitro. It is also able to bind DNA in the absence of Orc1-5 with high affinity. 
In vivo experiments present evidence on the ability of Orc6 to recruit the replication 
machinery to itself on DNA. Although this ability is less efficient than that of EBNA1, a 
viral factor, it is sufficiently strong to support autonomous replication of plasmids in 
human cell lines for at least four weeks. Truncated variants of the protein containing at 
least one of the predicted Orc1-5 interaction sites are sufficient to allow replication. This 
finding can be used to design autonomous-replicating plasmids for use in gene therapy. 
Mapping the interaction network of Orc6 leads to the conclusion that HsOrc6 is only 
weakly attached to pre-RC factors, and is likely to have an important role in mitosis and 
possibly be involved in other pathways. 
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8. Zusammenfassung 
Orc6 ist eine entscheidende Komponente der Initiationsmaschinerie der eukaryotischen 
Replikation. Molekulare Studien zur Funktion dieser Faktoren tragen nicht nur zum 
grundlegenden Wissen über Zellfunktionen bei, sondern auch zum Verständnis der 
Krankheiten, die durch Replikationsdefekte hervorgerufen werden.  
Der erste Schritt der Replikationsinitation ist die Rekrutierung des Origin Recognition 
Complex (ORC) an die DNA. Obwohl die unterschiedlichen ORC Komponenten  
hochkonserviert und gut erforscht sind, evolviert Orc6 schneller als die anderen ORC-
Mitglieder. Orc6 besitzt im Vergleich zu Orc1-5 eine andere, weniger verstandene 
Struktur und ist als einziges ORC Protein nicht Mitglied der AAA+ Familie.  
Die geringe Zahl an Studien über Orc6 in menschlichen Zellen und die geringe 
Berechenbarkeit der Ergebnisse in den Modelsystemen macht eine eingehende Analyse 
des HsOrc6 notwendig. 
Ziel dieser Arbeit ist es, die Rolle von Orc6 auf molekularer Ebene besser zu verstehen. 
Dazu studierte ich den Mechanismus der Orc6-Orc1-5 Interaktion, die DNA-Bindung 
von Orc6 in humanen Zellen, und generierte ein Protein-Interaktionsnetzwerk von Orc6.  
Als Ergebnis dieser Untersuchung konnte ich zeigen, dass Orc6 über seinen C-Terminus 
mit Orc1-5 interagiert. Es ist wahrscheinlich, dass eine zweite Interaktionsdomäne 
existiert, die vermutlich neben dem Kernlokalisierungssignal liegt. Orc6 wird zur 
Bindung von Orc1-5 an die DNA nicht benötigt, kann aber diese Bindung zumindest in 
vitro stabilisieren. Orc6 kann unabhängig von Orc1-5 mit hoher Affinität an DNA 
binden. 
In vivo Experimente deuten darauf hin, dass Orc6 die Rekrutierung von ORC an 
potentiellen Origins unterstützt. Das gerichtete Binden von Orc6 an ein Plasmid 
unterstützt die autonome Replikation über mindestens vier Wochen, auch wenn die 
Effizienz geringer ist, vergleichbar zu EBNA1. Deletionsmutanten von Orc6, die eines 
der beiden Interaktionsdomänen besitzen, sind ausreichend, um Replikation zu 
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induzieren. Dieses Ergebnis kann dafür benutzt werden, autonomreplizierende Plasmide 
zur Anwendung in Genetherapie zu generieren.  
Aus dem Interaktionsnetzwerkes von Orc6 geht hervor, dass HsOrc6 nur schwach an pre-
RC Faktoren assoziiert ist, die Interaktion mit mitotischen Faktoren ist sehr viel 
ausgeprägter, was auf eine wichtige Rolle Orc6 in der Mitose hindeutet. 
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10.1 Raw microscopy images 
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Figure 26. Raw images obtained from fluorescence microscopy. This figure contains the unedited 
microscopy images that supplement the ones presented in Figure 17. As several of these signals are faint, 
they are difficult to present in a printed format or on dimmed displays. To overcome this, Figure 17 
presents these images with edited color levels as a way to provide better visibility. As some of the color 
balancing applied there is not a linear transformation, here I included the raw images to show that the actual 
data obtained indeed supports the conclusions made, and that image manipulation does not introduce 
significant artifacts in this experiment. The DAPI column represents the blue color channel from the raw 
fluorescence microscopy image, Orc6 shows red, and Orc2 the green color channel for each cell line 
analyzed. A merged, color image is presented at the end of each row. The cartoons on the left display the 
fusion proteins of Orc6 expressed in each cell line. This experiment is detailed in chapter 5.1.9. 
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10.2 Glossary 
A Adenine 
AA Amino acid 
APC Anaphase promoting complex 
APS Ammonium peroxodisulphat 
ATP Adenosine-5’-triphosphate 
Bp (DNA) base pair 
BP Biological process 
BSA Bovine serum albumin 
C Cytosine 
Cdc6 Cell Division Cycle 6 
CpG Methyl-Cytosine-Guanine dinucleotide 
DAPI 4',6-diamidino-2-phenylindole 
DDK Dbf4 dependent kinase 
DMSO dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
DOC Na-Deoxicholate 
DS Dyad symmetry element 
DTT Dithiothreitol 
EBNA1 Epstein-Barr viral nuclear antigen I 
EBV Epstein-Barr virus 
EDTA Ethylenediaminetetraacetic acid 
FCS Fetal calf serum 
FR Family of repeats 
G Guanine 
GI GenInfo identifier 
GO Gene ontology 
HB Hypotonic buffer 
IP Immunoprecipitation 
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KAc Potassium acetate 
MCM Minichromosome maintenance complex 
NLS Nuclear localization signal 
OBP Origin binding protein 
ORC Origin recognition complex 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
pre-RC pre-replication complex 
R Adenine or Guanine (purine) 
RT Room temperature 
SDS Sodium dodecyl sulfate 
T Thymine 
TEMED Tetramethylethylenediamine 
Tris Trisaminomethane 
W Thymine or Adenine (weak bonds) 
scTetR Single chain Tet repressor domain 
Y Thymine or Cytosine (pyrimidine) 
YFP Yellow fluorescent protein 
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